1997

SORAN news.: Blantyre [Malawi] : SORAN, v Unique Identifier : AIDSLINE MED/9702645
Gutachten zu fachwissenschaftlichen Fragen der Einstufung von Arbeiten mit dem HIV-Virus in die Sicherheitsstufe S3.: Freiburg : Oko-Institut e.V., [1993] 76 p Unique Identifier : AIDSLINE MED/9704377; Jager M
1. Turkiye AIDS Kongresi (Uluslararasi katki ile), 12-15 Ocak 1993.: Istanbul : Istanbul Tip Fakultesi, [1993?] xii, 158 p Unique Identifier : AIDSLINE MED/9601958
Annual report of AIDS in Canada. 1994. Surveillance: Ottawa, Ont. : Bureau of HIV/AIDS and STD, Laboratory Centre for Disease Control, Health Canada, [1995] 1 v Unique Identifier : AIDSLINE MED/9611411
Participatory management in coping with AIDS.: [Dar es Salaam] Tanzania : ParProSo Group, 1994 vi, 116 p. : ill Unique Identifier : AIDSLINE MED/9706955
Ninfee alla deriva : aspetti psicosociali dell'AIDS e delle altre malattie a trasmissione sessuale.: Bologna : Pitagora editrice, c1995 vii, 149 p. : ill Unique Identifier : AIDSLINE MED/9708050; Lazzari C
HIV focus : a newsletter reporting on the Ryan White Title III(b) Program. Issue 1 (Aug. 1995)- of Programs for Special Populations: Bethesda, MD : The Division, [1995- v. : ill., ports Unique Identifier : AIDSLINE MED/9612110
Bad blood : crisis in the American Red Cross.: New York, NY : Kensington Books, c1996 xiv, 289 p. : ill., ports Unique Identifier : AIDSLINE MED/9707274; Reitman J
AIDS in Canada : annual report on AIDS in Canada. Dec. 1996- Surveillance: Ottawa, Ont. : Division of Hiv/AIDS Surveillance, Bureau of HIV/AIDS and STD, Laboratory Centre for Disease Control, Health Canada, c1996- v Unique Identifier : AIDSLINE MED/9705863
Legislative survey of state confidentiality laws, with specific emphasis on HIV and immunization : final report presented to the U.S. Centers for Disease Control and Prevention, the Council of State and Territorial Epidemiologists, the Task Force for Child Survival and Development, Carter Presidential Center.: 1996 iii, 172, 346 p Unique Identifier : AIDSLINE MED/9707914; Gostin LO; Lazzarini Z; Flaherty KM
Stopping AIDS : AIDS/HIV education and the mass media in Europe.: London ; New York : Longman, 1996 viii, 263 p. : ill Unique Identifier : AIDSLINE MED/9709772; Wellings K; Field B
Conference on advances in AIDS vaccine development : program book.: [Bethesda] : Division of AIDS, National Institute of Allergy and Infectious Diseases, [1996?] iv, 251 p Unique Identifier : AIDSLINE MED/9706921
AIDS : understanding the challenge.: Nairobi : ACE Communications, 1996 xi, 180 p. : ill., ports Unique Identifier : AIDSLINE MED/9706987; Tuju R
Medical management of HIV infection. 1996 ed.: Glenview, Ill. : Physicians & Scientists Pub. Co., c1996 ix, 303 p. : ill Unique Identifier : AIDSLINE MED/9706601; Bartlett JG
Dall'altra parte : la macchina contro l'Aids : storia di una sperimentazione.: Venezia : Marsilio, c1997 123 p. : ill (Gli specchi del presente) Unique Identifier : AIDSLINE MED/9705930; Marineo G
Sexual ecology : AIDS and the destiny of gay men.: New York : Dutton, c1997 xiii, 320 p Unique Identifier : AIDSLINE MED/9707203; Rotello G
The impact of AIDS psychological and social aspects of HIV infection.: Australia : Harwood Academic Publishers, c1997 xix, 250 p. : ill Unique Identifier : AIDSLINE MED/9708033; Catalan J; Sherr L; Hedge B
AIDS : the biological basis. 2nd ed.: Dubuque, IA : Wm. C. Brown Publishers, c1997 vii, 293 p. : ill., port Unique Identifier : AIDSLINE MED/9708356; Alcamo IE
AIDS : activism and alliances.: UK : Bristol, PA : Taylor & Francis, 1997 vii, 250 p (Social aspects of AIDS) Unique Identifier : AIDSLINE MED/9706668; Aggleton P; Davies P; Hart G
HIV/AIDS and sexually transmitted diseases.: [Geneva?] : World Health Organization, c1997 20 p Unique Identifier : AIDSLINE MED/9709895
Conference on Advances in AIDS Vaccine Development, 1997 : Ninth Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS, May 4-7, 1997 : program book. of AIDS: Bethesda, Md. : Division of AIDS, National Institute of Allergy and Infectious Diseases, [1997?] iv, 236 p Unique Identifier : AIDSLINE MED/9710489
Evaluating HIV prevention interventions.: New York : Plenum Press, c1997 xv, 295 p. : ill (AIDS prevention and mental health) Unique Identifier : AIDSLINE MED/9708579; Mantell JE; DiVittis AT; Auerbach MI
Urban health care.: State Health Care Am. 1993;:34-41. Unique Identifier : AIDSLINE MED/97360461; Shoor R; Public hospitals are straining under the burden of having to care for many of the poorest and sickest people in America. The health care problems of the nation s most disadvantaged include infectious diseases such as AIDS and tuberculosis, as well as problems related to violence and lack of access to primary care. Urb
The pharmaceutical industry.: State Health Care Am. 1993;:42-9. Unique Identifier : AIDSLINE MED/97360462; Lewis L; Siegelman S; Pharmaceutical research once focused primarily on curing infectious diseases, many of which have been virtually eliminated. Today, there is growing emphasis on finding ways to prevent, treat, and cure chronic illnesses such as cardiovascular disease and cancer.
Symposium: Issues in AIDS services delivery.: J Health Hum Serv Adm. 1997 Winter;19(3):235-318. Unique Identifier : AIDSLINE MED/97386282
Issues in AIDS services delivery: a symposium. Introduction.: J Health Hum Serv Adm. 1997 Winter;19(3):235-9. Unique Identifier : AIDSLINE MED/97373469; Liou KT
A tale of two health care delivery systems.: J Health Hum Serv Adm. 1997 Winter;19(3):240-56. Unique Identifier : AIDSLINE MED/97373470; Mor V; Stein M; Carpenter C; Mayer K; Brown University, USA.
AIDS services in Florida: who's doing what, and who's paying for it?: J Health Hum Serv Adm. 1997 Winter;19(3):257-69. Unique Identifier : AIDSLINE MED/97373471; Cruise PL; Florida Atlantic University, USA.; The rapid growth of AIDS in the 1980s was paralleled by a rapid growth in AIDS Service Organizations (ASOs) throughout the United States . This article examines one state, Florida, and the 52 ASOs to determine each ASOs organizational affiliation, major types of service offered, sources
Medicaid AIDS waivers: seeking cost effective financing of AIDS care.: J Health Hum Serv Adm. 1997 Winter;19(3):270-82. Unique Identifier : AIDSLINE MED/97373472; Dunn SM; Comprehensive AIDS Program of Palm Beach County, FL, USA.; The epidemic of Acquired Immunodeficiency Syndrome (AIDS) emerged at a time of transition in American health care and health care policy. The waiver of traditional Medicaid limitations on home and community-based health care services for persons with AIDS has been utilized by several states attempting to demonstrate m
Volunteer burnout and dropout: issues in AIDS service organizations.: J Health Hum Serv Adm. 1997 Winter;19(3):283-303. Unique Identifier : AIDSLINE MED/97373473; Gabard DL; Chapman University, CA, USA.
An analysis of employees' job involvement in a community-based AIDS service organization.: J Health Hum Serv Adm. 1997 Winter;19(3):304-18. Unique Identifier : AIDSLINE MED/97373474; Liou KT; University of Central Florida, USA.; This study analyzes employees job involvement in a community-based AIDS Service Organization (ASO). The study reveals that these employees have a relatively high level of job involvement and that three job-related factors are significantly correlated to the job involvement. The three factors are: employees perceived
If the condom breaks. A morning-after treatment for exposure to HIV might protect you from AIDS. But don't count on it.: Time. 1997 Jun 23;149(25):48. Unique Identifier : AIDSLINE MED/97390028; Gorman C
Can patients drive the future of health care?: Harv Bus Rev. 1997 Jul-Aug;75(4):146-50. Unique Identifier : AIDSLINE MED/97390020; Wyke A; Economist Intelligence Unit, London.; As the traditional system of health care in the United States gives way to a regime run increasingly by the private sector, a powerful force is emerging: the patient. According to Harvard Business School professor Regina Herzlinger, health care is much like other service industries. Pr
The effects of a participative programme on Irish pupils' attitudes to HIV/AIDS.: Health Educ Res. 1997 Jun;12(2):267-73. Unique Identifier : AIDSLINE MED/97375901; Swain R; McNamara M; Department of Applied Psychology, University College, Cork, Ireland.; The study is concerned with a general humanistic approach to health (lifeskills) education and its application to the specific issue of HIV/AIDS in the Republic of Ireland . A programme of five classroom sessions, structured to encou
Sexual behaviour in a fishing community on Lake Victoria, Uganda.: Health Transit Rev. 1997 Apr;7(1):13-20. Unique Identifier : AIDSLINE MED/97375902; Pickering H; Okongo M; Bwanika K; Nnalusiba B; Whitworth J; Medical Research Council/UVRI, Entebbe, Uganda.; This study describes the sexual behaviour of men and women in a fishing village on the shores of Lake Victoria in southwest Uganda . The village is near a well known trading town-truckstop on the main trans-Africa highway with a high recorded prevalence of HIV infection. Data were o
Socio-demographic correlates, HIV/AIDS-related cofactors, and measures of same-sex sexual behaviour among northern Thai male soldiers.: Health Transit Rev. 1997 Apr;7(1):33-60. Unique Identifier : AIDSLINE MED/97375903; London AS; VanLandingham MJ; Grandjean N; Department of Sociology, Kent State University, Ohio 44242-0001, USA.; We use data from an anonymous self-administered 1991 survey of military personnel in northern Thailand to estimate overall levels of and socio-demographic differentials in same-sex sexual behaviour in this population. Additionally, we examine the relationship between sexual exper
Too poor to treat. States are balking at paying for pricey AIDS drugs.: Newsweek. 1997 Jul 28;130(4):60. Unique Identifier : AIDSLINE MED/97400001; Pedersen D; Larson E
HIV prevention in Hungary.: Health Policy. 1997 Jun;40(3):231-6. Unique Identifier : AIDSLINE MED/97400022; Danziger R; Dept of Public Health and Policy, London School of Hygiene and; Tropical Medicine, London, UK.; Hungary is a country with relatively low HIV prevalence. Since 1989, a wide range of HIV prevention projects has been developed both by government agencies and by an increasingly active voluntary sector. While energy and resources c
Leukemia and lymphoma.: Leukemia and Lymphoma, Pathogenesis and Treatment, Molecular Aspects. 18th Symposium of the International Association for Competitive Research on Leukemia and Related Diseases. Kyoto, Japan, October 29 to November 3, 1995.. Unique Identifier : AIDSLINE MED/97618842; Anonymous; No affiliation given; The XVIII Symposium of the International Association for Comparative Research on Leukemia and Related Diseases, Leukemia and Lymphoma/Pathogenesis and Treatment/Molecular Aspects, was held October 29-November 3, 1995 in Kyoto, Japan . The symposium included plenary sessions on gene r
High level IL-2 expression vectors using HIV LTR in human colon carcinoma cell line (Meeting abstract).: Proc Annu Meet Am Assoc Cancer Res; 38:A217 1997. Unique Identifier : AIDSLINE MED/97619013; Vasanwala FH; Tsang TC; Liu F; Clark PR; Luznick L; Stopeck AT; Akaporiaye ET; Hersh EM; Harris DT; Department of Microbiology and Immunology, University of; Arizona,Tucson, AZ 84721; The success of IL-2 gene therapy is dependent on high expression of the gene product. Tumor cells transduced with IL-2 and intratumoral injection of IL-2 expressing plasmids result in effective antitumor activity in some tumors. We have developed two plasmid expression
Gene regulation of de novo cholesterol synthesis by 2,3,7,8-tetrachlorodibenzo-p-dioxin (Meeting abstract).: Proc Annu Meet Am Assoc Cancer Res; 38:A416 1997. Unique Identifier : AIDSLINE MED/97619102; Tian Y; Ke S; Germino JF; Meeker R; and Gallo MA; UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ 08855; The aryl hydrocarbon (Ah) receptor which is a ligand activated basic HLH transcription factor. The most potent ligand 2,3,7,8-TCDD, is a tumor promoter that dramatically alters lipid profiles in rodents. TCDD, at 1 ug/kg, causes a significant inhibition of cholesterol synthesis in liver and adipose tissue in rats. We
Analysis of IL-13 receptor structure identifies three different types of receptors which utilize two different types of cloned IL-13R alpha chains (Meeting abstract).: Proc Annu Meet Am Assoc Cancer Res; 38:A440 1997. Unique Identifier : AIDSLINE MED/97619122; Murata T; Obiri N; Puri R; Division of Cellular and Gene Therapy, CBER, FDA, Bethesda, MD 20892; We recently reported that IL-13 receptor (R) can be classified into at least three major types based on the patterns of IL-13 binding and interaction with IL-4. Recently, two different human IL-13R chains have been cloned from Caki-1 renal cell carcinoma RCC) and MT-2 HTLV-1 infected T cell lines (termed here alpha an
Misincorporation of dNTPs opposite 1,N2-ethenoguanine and 5,6,7,9-tetrahydro-7-hydroxy-9-oxo-imidazo[1,2-a]purine in oligonucleotides by Escherichia coli polymerases I exo- and II exo-, T7 polymerase exo-, HIV-1 reverse transcriptase, and rat polymerase beta (Meeting abstract).: Proc Annu Meet Am Assoc Cancer Res; 38:A251 1997. Unique Identifier : AIDSLINE MED/97619044; Langouet S; Muller M; Guengerich FP; Department of Biochemistry and Center in Molecular Toxicology,; Vanderbilt University School of Medicine, Nashville, Tennessee 37232; 1,N2-etheno(epsilon)guanine(Gua) and 5,6,7,9-tetrahydro-7-hydroxy-9-oxo-imidazo[1,2-a]purine HO-ethanoGua) are two modified bases formed in the reaction of DNA with 2-chlorooxirane the epoxide derivative of vinyl chloride. Both adducts incorporated in oligonucleotides retarded the 3 -extension of a complementary 10-me
Kinetics of deoxyribonucleotide insertion and extension at 8-oxo-7,8-dihydroguanine by T7 polymerase exo- and HIV-1 reverse transcriptase (Meeting abstract).: Proc Annu Meet Am Assoc Cancer Res; 38:A277 1997. Unique Identifier : AIDSLINE MED/97619069; Lowe LG; Einolf HJ; Guengerich FP; Department of Biochemistry and Center in Molecular Toxicology,; Vanderbilt University School of Medicine, Nashville, TN 37232; The replicative enzymes bacteriophage T7 pol exo- (T7-) and HIV-1 reverse transcriptase (HIV-1 RT) were used with a 24/36-mer sequence to examine the kinetics of incorporation of C and A at a site-specific 8-oxo-7,8-dihydroguanine (8-oxoGua). HIV-1 RT showed a high preference for insertion of A opposite 8-oxoGua. Stea
Black-bordered warning box for cidofovir.: Aids Patient Care STDS. 1997 Apr;11(2):100. Unique Identifier : AIDSLINE MED/97290229
Drug interaction advisory.: Aids Patient Care STDS. 1997 Apr;11(2):102. Unique Identifier : AIDSLINE MED/97290231
Pharmacia and Upjohn and Gilead sciences receive European recommendation for cidofovir.: Aids Patient Care STDS. 1997 Apr;11(2):102. Unique Identifier : AIDSLINE MED/97290230
Different clarithromycin doses affect mortality.: Aids Patient Care STDS. 1997 Apr;11(2):102-3. Unique Identifier : AIDSLINE MED/97290232
Hepatitis B and adefovir depivoxil.: Aids Patient Care STDS. 1997 Apr;11(2):103. Unique Identifier : AIDSLINE MED/97290233
NDA filed to treat refractory herpes.: Aids Patient Care STDS. 1997 Apr;11(2):103. Unique Identifier : AIDSLINE MED/97290234
Repertoire of safer sex tools and behavioral options is the key to HIV/STD prevention for women.: Aids Patient Care STDS. 1997 Apr;11(2):104. Unique Identifier : AIDSLINE MED/97290236
College girls get the message via role playing and small-group workshops.: Aids Patient Care STDS. 1997 Apr;11(2):105-6. Unique Identifier : AIDSLINE MED/97373500
HIV prevention programs aimed at women are cost-effective.: Aids Patient Care STDS. 1997 Apr;11(2):106. Unique Identifier : AIDSLINE MED/97290238
AIDS aware.: Aids Patient Care STDS. 1997 Apr;11(2):110-7. Unique Identifier : AIDSLINE MED/97290239
Important new findings concerning the pathophysiology and treatment of HIV/AIDS were presented at the 4th Conference on Retroviruses and Opportunistic Infections, held in Washington, DC, January 22-26, 1997 [editorial]: Aids Patient Care STDS. 1997 Apr;11(2):58-9. Unique Identifier : AIDSLINE MED/97290215; Laurence J
Delayed diagnosis of M. tuberculosis in an HIV-infected male.: Aids Patient Care STDS. 1997 Apr;11(2):60-1. Unique Identifier : AIDSLINE MED/97290216; Newshan G; Leon W; AIDS Center Program, St. Vincent's Hospital, New York, NY, USA.
Skin and mucosal characteristics of symptomatic primary HIV-1 infection.: Aids Patient Care STDS. 1997 Apr;11(2):67-70. Unique Identifier : AIDSLINE MED/97290218; Lapins J; Gaines H; Lindback S; Lidbrink P; Emtestam L; Department of Dermatovenereology, Huddinge Hospital, Karolinska; Institute, Sweden.
Atypical presentations of progressive multifocal leukoencephalopathy (PML): aseptic meningitis and Anton's syndrome.: Aids Patient Care STDS. 1997 Apr;11(2):71-5. Unique Identifier : AIDSLINE MED/97290219; Burns BT; Katner HP; Couch DA; Smith MU; Bhutta T; Stephens J; Department of Internal Medicine, Mercer University School of Medicine,; Macon, GA, USA.
Foscarnet administered by portable infusion device in AIDS patients with CMV infection.: Aids Patient Care STDS. 1997 Apr;11(2):76-8. Unique Identifier : AIDSLINE MED/97290220; Bicart-See A; Obadia M; Gonzalez C; Averous S; Maurette M; Auvergnat JC; Department of Infectious Diseases, Hopitaux de Toulouse, France.
The use of alternative therapies for HIV infection: implications for patient care.: Aids Patient Care STDS. 1997 Apr;11(2):79-85. Unique Identifier : AIDSLINE MED/97290221; Carwein VL; Sabo CE; University of Washington, Tacoma, USA.
The lived experiences of Winnipeg women with HIV/AIDS.: Aids Patient Care STDS. 1997 Apr;11(2):86-92. Unique Identifier : AIDSLINE MED/97290222; Nicolas S; Schilder E; Centre Medico Social DeSalaberry District Health Centre, St. Pierre; Jolys, Manitoba, Canada.
HIV/AIDS case histories: diagnostic problems.: Aids Patient Care STDS. 1997 Apr;11(2):93. Unique Identifier : AIDSLINE MED/97290223; Godwin JH; Godwin TA; Cornell University Medical College, USA.
Public policy update: an AmFAR report.: Aids Patient Care STDS. 1997 Apr;11(2):94-5. Unique Identifier : AIDSLINE MED/97290224; Silver J
Final CESARE trial results show continued clinical and survival benefit.: Aids Patient Care STDS. 1997 Apr;11(2):96. Unique Identifier : AIDSLINE MED/97290225
Study suggests initiating saquinavir in early disease may increase duration of response.: Aids Patient Care STDS. 1997 Apr;11(2):97-8. Unique Identifier : AIDSLINE MED/97290227
IgE-bearing cells and epsilon-specific mRNA in lymphoid organs of two children with AIDS.: Pediatr AIDS HIV Infect. 1997 Apr;8(2):102-7. Unique Identifier : AIDSLINE MED/97323595; Auci DL; Smith-Norowitz T; Jagoo AD; Kleiner GI; Bluth MH; Chice SM; Bard E; Anderson V; Zevallos E; Durkin HG; Department of Pathology, State University of New York Health Science; Center at Brooklyn 11203, USA.; To characterize the cellular basis of IgE responses in HIV-positive (HIV+) children, we obtained central (bone marrow [BM], thymus) and peripheral (Peyer s patches [PP], mesenteric [MLN], and other lymph nodes [OLN], spleen), lymphoid organs from two children with AIDS (females, 2 and 8 years old), and from a non-HIV-
Risk and resilience in the cognitive functioning of children born to HIV-1-infected mothers: a preliminary report.: Pediatr AIDS HIV Infect. 1997 Apr;8(2):108-13. Unique Identifier : AIDSLINE MED/97323596; Coscia JM; Christensen BK; Henry RR; Department of Psychology, Vanderbilt University, Nashville, Tennessee; 37203, USA.; Although biologic and environmental risk factors show an age-dependent effect on children s cognitive development, outcome studies have yet to consider the role such factors play in the development of children born to HIV-1-infected women. This study explored the age-dependent differential impact of such risk factors
HIV-1 infection in a population-based twin sample.: Pediatr AIDS HIV Infect. 1997 Apr;8(2):114-9. Unique Identifier : AIDSLINE MED/97323597; Krasinski K; Turner BJ; Hauck WW; Fanning TR; New York University Medical Center-Bellevue Hospital Center, New York,; USA.; OBJECTIVE: To examine factors associated with perinatal HIV-1 transmission among twins. METHODS: We identified twins delivered by a population-based cohort of HIV-infected mothers on New York State Medicaid. Tested algorithms were applied to Medicaid files to identify HIV infection in mothers and twins. The HIV transm
Phosphorylated zidovudine concentrations in mononuclear cells in pediatric patients with human immunodeficiency virus infections.: Pediatr AIDS HIV Infect. 1997 Apr;8(2):120-6. Unique Identifier : AIDSLINE MED/97323598; Wintermeyer SM; Nahata MC; Brady MT; Sobol BJ; Venglarcik JS 3rd; Baker RC; Hunkler JA; McOwen NM; Children's Medical Center of Northwest Ohio, Toledo, USA.; PURPOSE: The efficacy of zidovudine (ZDV) in patients with HIV-1 infection may decrease over time due to its decreased activation. The objectives of this study were to determine ZDV concentrations in plasma, active phosphorylated zidovudine (pZDV) concentrations in mononuclear cells, and assess the markers of immune f
In vitro antibody production (IVAP) in the follow-up of pediatric human immunodeficiency virus type 1-infected patients.: Pediatr AIDS HIV Infect. 1997 Apr;8(2):127-9. Unique Identifier : AIDSLINE MED/97323599; Rusconi S; Riva A; Cocchi F; Massironi E; Tornaghi R; de Maddalena C; de Pasquale MP; Galli M; Clinica delle Malattic Infettive, Universita di Milano, Ospedale Luigi; Sacco, Italy.
HIV infection in women and children: where are we headed? [editorial]: Pediatr AIDS HIV Infect. 1997 Apr;8(2):86-8. Unique Identifier : AIDSLINE MED/97323591; Helfgott AW
HIV testing--time for a change [editorial]: Pediatr AIDS HIV Infect. 1997 Apr;8(2):89-90. Unique Identifier : AIDSLINE MED/97323592; Caplan AL
HIV-infected children with hemophilia: one- and two-year follow-up of neuropsychological functioning.: Pediatr AIDS HIV Infect. 1997 Apr;8(2):91-7. Unique Identifier : AIDSLINE MED/97323593; Hooper SR; Whitt JK; Tennison MB; Burchinal M; Gold SH; Hall CD; Department of Psychiatry, University of North Carolina, Chapel Hill,; USA.; This report describes the absence of neuropsychologic change observed over a 2-year period for 25 HIV-seropositive (HIV+) children and adolescents with hemophilia and 33 HIV-seronegative HIV-) controls. Efforts were made to match the groups on the basis of chronological age, race, and hemophilia severity. The baseline
Hepatitis B, syphilis, and human immunodeficiency virus: are different approaches to prenatal screening justified?: Pediatr AIDS HIV Infect. 1997 Apr;8(2):98-101. Unique Identifier : AIDSLINE MED/97323594; Grimes RM; Richards EP; Rathbun KC; AIDS Education and Training Center for Texas and Oklahoma, University; of Texas--Houston Health Science Center, School of Public Health; 77225-0186, USA.
Chances dim for fiscal `97 boost in AIDS drug funds. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 13;12(11):1, 10. Unique Identifier : AIDSLINE MED/97702672; Congressional leaders rejected a proposal to supplement Federal funding for State-run AIDS drug assistance programs (ADAP), and President Clinton refused to intervene. A proposal by Rep. Nancy Pelosi (D-CA) that included $68 million in additional ADAP funding was part of a supplemental appropriations bill aimed largel
Clinton sets goal of having an AIDS vaccine in 10 years. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 13;12(11):3. Unique Identifier : AIDSLINE MED/97702673; During a May 18, 1997 commencement address at Morgan State University, President Clinton announced the establishment of a new AIDS vaccine research center within the National Institutes of Health (NIH) and called for accelerated development of an AIDS vaccine. Clinton appealed to foreign governments and pharmaceutical
Washington adopts measure for testing prison inmates. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 13;12(11):4-5. Unique Identifier : AIDSLINE MED/97702674; Governor Gary Locke of Washington State signed legislation that attempts to balance the privacy interests of HIV-positive prison inmates with the safety needs of corrections officers. Bill 1605 limits disclosure of HIV-positive test results to healthcare administrators or infection-control coordinators in State and lo
Washington toughens sanctions against intentional exposure. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 13;12(11):4. Unique Identifier : AIDSLINE MED/97702675; Governor Gary Locke of Washington State signed a law that will impose stronger penalties against people who intentionally expose others to HIV. The Governor vetoed a provision authorizing court-ordered detention of those who continue to practice dangerous sexual behavior. The bill raises the penalty for the crime of i
Needle-exchange programs: a prickly debate.: AIDS Policy Law. 1997 Jun 13;12(11):6-8. Unique Identifier : AIDSLINE MED/97702677; Kim B; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Statistical Assessment Service, Washington, DC.; The proportion of new HIV cases among intravenous drug users is increasing steadily. One proposed solution is a federally funded and coordinated needle-exchange program (NEP). Recent developments in the needle-exchange debate highlight the difficulties in answering questions about NEP s effectiveness and appropriatene
N.J. governor vetoes mandatory testing of psychiatric patients. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 13;12(11):8. Unique Identifier : AIDSLINE MED/97702678; New Jersey Governor Christie Whitman conditionally vetoed a bill that would have mandated HIV testing of all patients in State psychiatric hospitals. The bill would have required patients upon admission to undergo testing for HIV, hepatitis B, hepatitis C, syphilis, gonorrhea, and other sexually transmitted diseases.
Judge suspends Kentucky law banning home test kits. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 13;12(11):9, 11. Unique Identifier : AIDSLINE MED/97702679; Franklin County (Kentucky) Court Judge William Graham signed an order temporarily barring the State from enforcing a statute that bans the marketing or sale of home HIV test kits. Home Access Health Corporation sought the injunction after it learned of the existence of a law making it a felony for anyone to sell, dist
Notification scrapped. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 13;12(11):12. Unique Identifier : AIDSLINE MED/97702681; The Health Department of Puerto Rico aborted plans to require individuals who test positive for HIV to report names of their sex partners to public health workers. The partner notification proposal will be converted to a voluntary program. The controversial provision would have
Stalled vaccine effort gets new boost in U.S. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Jul;12(7):73-5. Unique Identifier : AIDSLINE MED/97702683; Development of an AIDS vaccine has slowed, partly due to the perception that new drugs, such as protease inhibitors , are so effective that vaccines will not be needed to eradicate the disease. However, since 98 percent of new cases take place in developing countries
CDC guidance expected for high-risk sexual exposure. Centers for Disease Control and Infection. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Jul;12(7):75-7. Unique Identifier : AIDSLINE MED/97702684; The Centers for Disease Control and Prevention (CDC) is expected to issue recommendations for prophylactic treatment for health care workers exposed to HIV on the job. The post-exposure protocol will include a three-drug regimen for severe exposures, and it is likely that newer drugs, such as nelfinavir, will be inclu
New AIDS study suppresses T cells to stop viral growth. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Jul;12(7):77-8. Unique Identifier : AIDSLINE MED/97702685; A controversial new study of the experimental drug BCX-34 is underway by Biocryst Pharmaceuticals. The drug suppresses T cells, a radically different approach; however, the drug is highly reversible. T cell counts return to pretreatment levels within two weeks after the drug is discontinued. The drug is already in Pha
Needle-exchange issue put on front burner. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Jul;12(7):79-80. Unique Identifier : AIDSLINE MED/97702686; There are renewed pressures on the Federal government to lift the ban on needle exchange programs and to devote more funds to fighting what is the primary mode of HIV transmission in the United States . More than one-third of the 548,000 AIDS cases in the U.S. are attributed to injectio
New treatments give HIV reporting added weight. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Jul;12(7):80-3. Unique Identifier : AIDSLINE MED/97702687; The success of early combination therapy has underscored the importance of early detection, but is spurring efforts at both the State and Federal levels to push for mandatory HIV reporting. Protease inhibitors have precipitated the debate over a public health approach
FDA explores new antiretroviral trial designs: interview with David Feigal, M.D. [interview by John S. James]: AIDS Treat News. 1997 Jun 20;(No 273):1-5. Unique Identifier : AIDSLINE MED/97702688; Feigal D; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; At its public meeting, July 14 and 15, the Food and Drug Administration s ( FDA ) Antiviral Drugs Advisory Committee will explore ways to design clinical drug trials so that they are completed faster and more safely. The FDA is considering changing the clinical endpoints requirement for
Protease inhibitors: FDA warns doctors of diabetes risk. Food and Drug Administration. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Treat News. 1997 Jun 20;(No 273):5-6. Unique Identifier : AIDSLINE MED/97702689; The Food and Drug Administration ( FDA ) is warning AIDS physicians that there may be a slight risk of developing diabetes and hyperglycemia among patients receiving protease inhibitor therapy. The attack rate appears to be less than one percent and the FDA is not suggesting discontinui
1592: protests on small access program. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Treat News. 1997 Jun 20;(No 273):6-8. Unique Identifier : AIDSLINE MED/97702690; Glaxo Wellcome has announced a small compassionate use program for its experimental drug, 1592 ( abacavir ). The program will make 1592 available to 2,500 adults and children in countries where the drug is a
Three States consider raising penalties for exposure to HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 27;12(12):1, 5. Unique Identifier : AIDSLINE MED/97702691; Lawmakers in California, New Jersey, and Alaska voted to impose stronger penalties on individuals who expose others to HIV through sex or drug needles. Each of the three States senates voted to approve stronger penalties based on high profile cases involving men who knowingly transmitted HIV to women, or threatened t
Soldier loses bid to contest Army's safer-sex order. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 27;12(12):2. Unique Identifier : AIDSLINE MED/97702693; The U.S. Supreme Court refused to review an appeal by an HIV-infected soldier, Carinel Pritchard, Jr., who claimed he was wrongly imprisoned for having unprotected sex with his wife. The high court said it would not consider the soldier s argument that the Army violated his marital privacy rights. Pritchard acknowledg
Court says inmate not harmed by suspension of HIV drug. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 27;12(12):2. Unique Identifier : AIDSLINE MED/97702694; The 6th U.S. Circuit Court of Appeals ruled that a prisoner denied access to AZT for three days did not suffer cruel and unusual punishment. Thaddeus-X, an inmate in Jackson, MI, appealed a lower court dismissal of civil rights claims. The corrections
CDC considers 'morning after' therapy for sexual exposure. Centers for Disease Control and Prevention. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 27;12(12):4. Unique Identifier : AIDSLINE MED/97702696; The Centers for Disease Control and Prevention (CDC) will convene a panel to consider sanctioning a morning after treatment to prevent HIV transmission from sex with an infected partner. The meeting was prompted by advocates who say people exposed to HIV should be given the same antiretroviral therapy recommended in t
Needle-exchange bill passes California senate by one vote. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 27;12(12):4. Unique Identifier : AIDSLINE MED/97702697; California s Senate approved legislation authorizing experimental needle-exchange programs in four cities: San Francisco, Los Angeles, San Jose, and Long Beach. Officials in these cities will decide whether their city will participate. The proposed legislation cited several studies showing that HIV transmission rates
Study shows condom use does not promote promiscuity. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 27;12(12):6-7. Unique Identifier : AIDSLINE MED/97702698; Researchers from Switzerland s Lausanne University Institute of Social and Preventative Medicine report the results of a media and school-based prevention education program that promoted condom use, sexual abstinence, and marital fidelity. Findings indicated that condom usage has increased dramatically and people are
49 States poised to accept Federal aid to teach abstinence. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 27;12(12):6. Unique Identifier : AIDSLINE MED/97702699; A Federal program offering funds to States that implement an abstinence-only curriculum for school children is being well received in every State except Wyoming. In Wyoming, a task force recommended that the governor not accept the money because it amounts to federally-dictated morality. The program gives $4 in Federa
Evidence of AIDS dementia may void defendant's guilty plea. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 27;12(12):7. Unique Identifier : AIDSLINE MED/97702700; A three-judge panel of the 4th U.S. Circuit Court of Appeals said that a district court failed to address Dee Deirdre Farmer s AIDS-related dementia when she entered a guilty plea on credit card fraud. Farmer is a male-to-female transsexual who did not learn she was mentally impair
Court reverses finding of discrimination in dental practice. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 27;12(12):9. Unique Identifier : AIDSLINE MED/97702702; A New York appeals court annulled a $25,000 damage award after concluding that there was insufficient proof to support a finding that dentists Edward Anker, Jeffrey Schulman, and Jules Shteierman discriminated against a patient because of his HIV status. The dentists appealed to the States s Supreme Court Appellate Di
Jury sees racial bias in Philadelphia's top AIDS agency. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 27;12(12):11. Unique Identifier : AIDSLINE MED/97702703; The former director of Philadelphia s AIDS Activities Coordinating Office was found guilty of violating the civil rights of four employees by denying them promotions or stripping them of responsibilities because of their race. A Federal jury determined that Richard Scott, who directed the office from 1993 to 1994, pas
Adherence, compliance, and HAART.: AIDS Clin Care. 1997 Jul;9(7):51-4, 58. Unique Identifier : AIDSLINE MED/97702704; Williams A; Friedland G; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Yale / New Haven Hospital, AIDS Care Program, New Haven, CT.; The development and use of new, highly active antiretroviral therapy (HAART) requires a discussion of a factor that is key to the success of these regimens, i.e., patient adherence. The term compliance is more often used, but adherence is the preferred term and considered more accurate because it implies and recognize
Treating a survivor.: AIDS Clin Care. 1997 Jul;9(7):55, 58. Unique Identifier : AIDSLINE MED/97702705; Zuger A; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; A case study is presented of a 27-year-old male, in the late stages of AIDS, who benefitted from recent advances in HIV therapy. During recovery from his fourth episode of pneumocystis pneumonia and newly-diagnosed disseminated Mycobacterium avium MAC) infection, he agreed to take antiretrovirals. He received treatmen
3TC receives full approval.: Posit Aware. 1997 May/Jun;8(3):11. Unique Identifier : AIDSLINE MED/97702706; Grodeck B; Vazquez E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; 3TC ( Epivir /lamivudine) has received full Food and Drug Administration ( FDA ) approval following its accelerated approval in November 1995. It has sho
Volunteers wanted to study HIV treatments. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Posit Aware. 1997 May/Jun;8(3):14. Unique Identifier : AIDSLINE MED/97702707; The National Institutes of Health (NIH) is soliciting volunteers for several studies of new treatments for HIV and AIDS. Studies are planned for treatments for MAC and CMV retinitis, as well as for several new antiviral agents and vaccines. The agency will fly p
T-cell basics.: Posit Aware. 1997 May/Jun;8(3):20-1, 25. Unique Identifier : AIDSLINE MED/97702709; Munk B; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; HIV Coordinating Council of New Mexico, Albuquerque, NM.; T cell counts played a major role in monitoring HIV progression and treatment prior to the development of viral load testing. Drugs now being prescribed not only reduce viral load, but frequently cause a rebound in T cell counts. The role of T cells is described. Research is underway to address the question of whether
Arms buildup. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Posit Aware. 1997 May/Jun;8(3):26-7. Unique Identifier : AIDSLINE MED/97702710; DHEA (dehydroepiandrosterone) is the latest is a series of trendy drugs that may build body mass and increase energy, and has become popular with the general public. DHEA may also have value in HIV treatments by boosting T cell counts, lowering viral load, and preventing wasting; however, tests are inconclusive. DHEA
Is your doctor competent?: Posit Aware. 1997 May/Jun;8(3):28-31. Unique Identifier : AIDSLINE MED/97702711; Condor B; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Chicago Tribune, Chicago, IL.; HIV-positive patients are consistently healthier and live longer when their care is managed by a physician with significant experience in treating HIV and AIDS, and it is essential for patients to seek out health care providers who keep up with current treatment guidelines. Experienced doctors generally offer more agg
Party at your own risk.: Posit Aware. 1997 May/Jun;8(3):32-7. Unique Identifier : AIDSLINE MED/97702712; Cox S; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Recreational drug use in patients on antiviral therapy can have fatal consequences. Levels of the drug Ecstasy can be increased dangerously in people taking ritonavir , especially in people with some liver dysfunction. There are few studies being done
Yellow alert. What you need to know about HIV and viral hepatitis.: Posit Aware. 1997 May/Jun;8(3):40-2, 45-6. Unique Identifier : AIDSLINE MED/97702713; Beaubien G; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Most experts recommend hepatitis vaccines for people who are HIV-positive as the risk factors for both diseases are similar, but there is no firm link between viral hepatitis and the health or longevity of people with HIV. There are five forms of hepatitis, with varying health impacts, and experts estimate that as man
Limited immune recovery after treatment with antiretrovirals, IL-2; interview with Clifford Lane, M.D. [interview by John S. James]: AIDS Treat News. 1997 Jun 6;(No 272):1-5. Unique Identifier : AIDSLINE MED/97702715; Lane C; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Clifford Lane, M.D., Clinical Director of the U.S. National Institute of Allergy and Infectious Disease (NIAID), responds to questions about changes in the immune system after treatment with antiretroviral agents and interleukin-2. Dr. Lane indicates that the degree of immune restoration after treatment with these age
Nelfinavir is number 4 -- but should it bat cleanup, or lead off?: J Int Assoc Physicians AIDS Care. 1997 Jun;3(6):17-21. Unique Identifier : AIDSLINE MED/97702716; Mascolini M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Critical issues are addressed concerning when to use nelfinavir, a newly approved protease inhibitor. Because of a resistance mutation that occurs as a result of taking nelfinavir, the following questions arise: if resistance emerges in a patient naive to protease inhibitor therapy, will that person be able to take an
Leishmaniasis in HIV-infected persons: a review.: J Int Assoc Physicians AIDS Care. 1997 Jun;3(6):22-39. Unique Identifier : AIDSLINE MED/97702717; Paredes R; Laguna F; Clotet B; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Hospital Universitari Germans Trias i Pujol, , Barcelona, Spain.; Leishmaniasis, a group of syndromes caused by a number of species of the dimorphic protozoa Leishmania, is discussed in terms of its pathogenesis, natural history, and clinical presentation as influenced by AIDS. The various types of leishmaniasis can affect many areas of the body and have numerous different clinical
How far can you knock down HIV? An interview with David D. Ho, MD. [interview by Mark Mascolini]: J Int Assoc Physicians AIDS Care. 1997 Jun;3(6):40-4. Unique Identifier : AIDSLINE MED/97702718; Ho DD; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Dr. David Ho discusses the degree to which HIV can be eradicated in the system using antiretroviral therapy containing protease inhibitors . Dr. Ho reports that among 20 patients remaining on his study using either
Predicting antiviral compliance: physicians' responsibilities vs. patients' rights.: J Int Assoc Physicians AIDS Care. 1997 Jun;3(6):45-8. Unique Identifier : AIDSLINE MED/97702719; Senak M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; AIDS Project Los Angeles, Los Angeles, CA.; Predicting which patients will comply with anti-HIV drug regimens is a very serious issue, since lack of compliance may cause development of drug-resistant strains of HIV that can be passed on to others. Ethical issues include addressing the well-being of the patient versus public health. Physicians are put in the pos
AIDS patients sought for study with NTZ for cryptosporidiosis. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: J Int Assoc Physicians AIDS Care. 1997 Jun;3(6):48. Unique Identifier : AIDSLINE MED/97702720; Patients are being recruited for a phase II/III trial using nitazoxanide for cryptosporidiosis. This is a six-week, double-blind, placebo-controlled trial to determine the efficacy and safety of nitazoxanide in HIV-positive patients with cryptosporidiosis. More information can be obtained by calling AIDS Clinical Tria
AIDS medical glossary. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: GMHC Treat Issues. 1997 Jun;11(6):1-36. Unique Identifier : AIDSLINE MED/97702736; A glossary of AIDS medical terms is presented. The glossary includes a list of alternate names for commonly prescribed medications. Definitions of drugs, treatments, opportunistic diseases, and types of cells are provided.
[Protease inhibitors]: Sidahora. 1996 Dec - 1997 Jan;:39-44. Unique Identifier : AIDSLINE MED/97702750; Markowitz M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; New York University, Medical Center, New York, NY.; Basic questions about protease inhibitors , drugs that are used to slow the spread of the HIV virus, are answered. Definitions of HIV infection and AIDS, HIV protease, and protease inhibitors are given. How protease inhibitors work, which inhibitors are in current st
STDs, HIV, and crack cocaine: a review.: Aids Patient Care STDS. 1997 Apr;11(2):62-6. Unique Identifier : AIDSLINE MED/97290217; Wilson T; DeHovitz JA; Department of Preventive Medicine and Community Health, State; University of New York, Health Science Center, Brooklyn, USA.
FDA Advisory Committee stalemates on delavirdine.: Aids Patient Care STDS. 1997 Apr;11(2):96-7. Unique Identifier : AIDSLINE MED/97290226
Human chorionic gonadotropin's benefit in KS may only be cosmetic.: Aids Patient Care STDS. 1997 Apr;11(2):100. Unique Identifier : AIDSLINE MED/97290228
Empowering women marginalized by prostitution and drug abuse requires a different approach.: Aids Patient Care STDS. 1997 Apr;11(2):104-5. Unique Identifier : AIDSLINE MED/97290237
Court broadens its ruling in Maine HIV dental case. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 13;12(11):1-2. Unique Identifier : AIDSLINE MED/97702671; The 1st U.S. Circuit Court of Appeals in Maine reviewed a crucial paragraph in its 33-page opinion in Abbott v. Bragdon, the case of a dental patient denied care because of her HIV infection. According to the plaintiff, Ms. Sidney Abbott, the revision made a narrow ruling much broader. In the original ruling, the cour
Judge: don't wait for ADA review to file rehab act claim. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 13;12(11):5. Unique Identifier : AIDSLINE MED/97702676; John Cebuhar sued the Illinois Department of Alcoholism and Substance Abuse (DASA) after he was denied reasonable accommodation for his HIV condition and then was terminated. Cebuhar said DASA and three top officials violated the two disability rights statutes as well as his constitutional right to equal protection un
High court won't review AIDS medical cap on ex-employee. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 13;12(11):11. Unique Identifier : AIDSLINE MED/97702680; The U.S. Supreme Court refused to review an appeals court ruling holding that former employees cannot use the Americans with Disabilities Act (ADA) to challenge AIDS-related discrimination in post-employment fringe benefits. The high court s decision relates to the estate of Timothy Bourgeois, fired from his job at a
AIDS cap on medical insurance violates the ADA, judge rules. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 27;12(12):1, 10. Unique Identifier : AIDSLINE MED/97702692; A Federal judge in Atlanta found that World Insurance Company failed to give a rational explanation for its decision to cap lifetime AIDS benefits at $5,000 when most other medical conditions had a $2 million cap. In so doing, the company has violated Title III of the Americans with Disabilities Act (ADA). Policyholde
Doctor who lost her job due to HIV allowed to continue suit. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 27;12(12):3. Unique Identifier : AIDSLINE MED/97702695; U.S. District Judge Wayne R. Anderson rejected as premature a defense motion to dismiss an Americans with Disabilities Act ADA) claim filed by a physician who states she was denied employment at the Family Health Care Associates Clinic after she was diagnosed as HIV-positive. The judge said that depositions will have
How much does it cost to settle a discrimination claim? Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jun 27;12(12):8-9. Unique Identifier : AIDSLINE MED/97702701; Summaries of recent out-of-court settlements in HIV discrimination lawsuits are provided. HIV discrimination suits are costly and the awards do not usually take into consideration the employer s other costs, such as attorney s fees and lost production time. The out-of-court settlements also involve non-monetary conseq
Delavirdine gets the green light.: Posit Aware. 1997 May/Jun;8(3):18-9. Unique Identifier : AIDSLINE MED/97702708; Vazquez E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; The Food and Drug Administration ( FDA ) approved delavirdine Rescriptor ) under its accelerated approval guidelines. The non-nucleoside reverse transcr
Double dose. Twin epidemics of addiction and HIV create special medical needs.: Posit Aware. 1997 May/Jun;8(3):48-51, 55-6. Unique Identifier : AIDSLINE MED/97702714; Vazquez E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; HIV-positive people who abuse drugs compromise their health through the life-threatening behavior. Treatment is difficult or hard to get for people who have no job or insurance, and health care is complicated when addicts engage in high-risk activities that can cause further health problems. Denial and distrust are co
[Living with HIV in recovery] Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Sidahora. 1996 Dec - 1997 Jan;:7-11. Unique Identifier : AIDSLINE MED/97702748; Addictions are not limited to only drugs and alcohol. People can also develop addictions to food, work, money, religion, and sex. The issue of addiction and HIV is addressed in detail. Several aspects of addiction are described, including various types of addictions, their associated behaviors, and definitions of addi
[Drugs, AIDS, and recovery. "Something else will be revealed"]: Sidahora. 1996 Dec - 1997 Jan;:14-5. Unique Identifier : AIDSLINE MED/97702749; Clavell MA; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; AIDS and drug use are serious and lethal problems. Substance abuse among people living with HIV/AIDS is increasing. An addict relates his personal experiences and anecdotes to advise others who are addicted to drugs and are living with HIV/AIDS.
Intestinal co-infection by Cyclospora sp. and Cryptosporidium parvum: first report in an AIDS patient.: Parasite. 1994 Dec;1(4):387-90. Unique Identifier : AIDSLINE MED/97285247; Scaglia M; Gatti S; Bassi P; Viale PL; Novati S; Ranieri S; Laboratory of Clinical Parasitology, University-IRCCS S. Matteo,; Pavia, Italy.; Cyclospora is recently described new human pathogenic coccidian causing intermittent diarrhoeal enteritis which may persist for weeks or months in immunocompetent subjects, particularly travellers visiting some tropical areas and countries, such as
The isolation of Leishmania donovani MON-18, from an AIDS patient in Portugal: possible needle transmission.: Parasite. 1994 Dec;1(4):391-2. Unique Identifier : AIDSLINE MED/97285248; Campino L; Santos-Gomes G; Pratlong F; Dedet JP; Abranches P; Instituto de Higiene e Medicina Tropical (IHMT), Lisboa, Portugal.; The spread of HIV infection into leishmaniasis endemic areas has increased the incidence of immunosupressed patients with kalaazar in Portugal . The dermotropic zymodeme MON-24 of leishmania infantum has been already isolated from a
Idiopathic CD4+ T-lymphocytopenia and recurrent vulvar intraepithelial neoplasia.: Obstet Gynecol. 1994 Oct;84(4 Pt 2):712-4. Unique Identifier : AIDSLINE MED/97349539; Park K; Monk BJ; Wilczynski S; Ito JI Jr; Vasilev SA; Department of Gynecologic Oncology, City of Hope National Medical; Center, Durate, California, USA.; BACKGROUND: CD4+ T-lymphocytopenia immunodeficiency without human immunodeficiency virus (HIV) infection has been reported recently. The association between immunodeficiency and anogenital neoplasia secondary to human papillomavirus infections is well documented. CASE: A woman with recurrent vulvar intraepithelial neo
Pathogenicity of Cyclospora sp [letter]: Parasite. 1994 Mar;1(1):94. Unique Identifier : AIDSLINE MED/97285209; Garavelli PL
Kinetics of HIV-1 RNA concentration changes in pediatric patients.: Pathobiology. 1996;64(6):289-94. Unique Identifier : AIDSLINE MED/97302775; Zeichner SL; Mueller BU; Pizzo PA; Dimitrov DS; HIV and AIDS Malignancies Branch, National Cancer Institute, NIH,; Bethesda, MD 20892, USA. Zeichner@nih.gov; Recent studies have used potent antiviral agents to investigate the kinetics of HIV infection in vivo. They provided estimates for important kinetic parameters, including the decay constants for circulating virus and infected CD4+cells. However, since all of these studies fundamentally rely on the use of antiviral age
Neuronal damage and its relation to dementia in acquired immunodeficiency syndrome (AIDS).: Pathobiology. 1996;64(6):295-307. Unique Identifier : AIDSLINE MED/97302776; Trillo-Pazos G; Everall IP; Department of Neuropathology, Institute of Psychiatry, London, UK.; There are an estimated 21.8 million people infected with human immunodeficiency virus (HIV) worldwide [Weekly Epidemiol Rec 1996; 27:204-208] and 90% of these people will have some form of neuropathological abnormality during the course of acquired immunodeficiency syndrome (AIDS). In this review, we will highlight th
Human T cell leukemia virus type I (HTLV-I) and human diseases.: Annu Rev Immunol. 1997;15:15-37. Unique Identifier : AIDSLINE MED/97288729; Uchiyama T; Institute for Virus Research, Kyoto University, Japan.; tuchiyam@virus1.virus.kyoto-u.ac.jp; HTLV-I infection is causally associated with a variety of human diseases including leukemia/lymphoma, myelopathy, uveitis, and arthropathy. Tax protein of HTLV-I, which is considered oncogenic, binds to transcription factors or other cytoplasmic cellular molecules involved in the fundamental cell function and thereby
Escape of human immunodeficiency virus from immune control.: Annu Rev Immunol. 1997;15:271-96. Unique Identifier : AIDSLINE MED/97288738; McMichael AJ; Phillips RE; Nuffield Department of Medicine, Institute of Molecular Medicine, John; Radcliffe Hospital, Oxford, United Kingdom.; andrew.mcmichael%mailgate.jr2@ox.ac.uk; Cytotoxic T lymphocytes (CTL) play a crucial role in the attempt to control infection with human immunodeficiency virus (HIV). Variation in epitopes recognized by CTL is common and frequently offers potential escape routes for mutant virus. Proof of escape, however, requires demonstration of increased frequency of vir
Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches.: Annu Rev Immunol. 1997;15:297-322. Unique Identifier : AIDSLINE MED/97288739; Constant SL; Bottomly K; Section of Immunobiology, Yale University School of Medicine, New; Haven, Connecticut, USA.; T helper lymphocytes can be divided into two distinct subsets of effector cells based on their functional capabilities and the profile of cytokines they produce. The Th1 subset of CD4+ T cells secretes cytokines usually associated with inflammation, such as IFN-gamma and TNF and induces cell-mediated immune responses.
Redox regulation of cellular activation.: Annu Rev Immunol. 1997;15:351-69. Unique Identifier : AIDSLINE MED/97288741; Nakamura H; Nakamura K; Yodoi J; Institute for Virus Research, Kyoto University, Japan.; Growing evidence has indicated that cellular reduction/oxidation redox) status regulates various aspects of cellular function. Oxidative stress can elicit positive responses such as cellular proliferation or activation, as well as negative responses such as growth inhibition or cell death. Cellular redox status is mai
Bone marrow-derived dendritic cells, infection with human immunodeficiency virus, and immunopathology.: Annu Rev Immunol. 1997;15:593-615. Unique Identifier : AIDSLINE MED/97288750; Knight SC; Patterson S; Antigen Presentation Research Group, Imperial College School of; Medicine at Northwick Park Institute for Medical Research, Harrow,; Middlesex, United Kingdom.; Dendritic cells (DC) exposed to HIV-1 show nonproductive infection that may become productive as they mature. The distribution of DC within genital mucosa and their susceptibility to infection particularly with clade E viruses could be reflected in the ease of heterosexual transmission. Carriage of virus and viral ant
Role of complement in HIV infection.: Annu Rev Immunol. 1997;15:649-74. Unique Identifier : AIDSLINE MED/97288752; Stoiber H; Clivio A; Dierich MP; Institut fur Hygiene, Innsbruck, Austria. Stoiber.hygiene@uibk.ac.at; In human plasma, HIV activates the complement system, even in the absence of specific antibodies. Complement activation would, however, be harmful to the virus if the reactions were allowed to go to completion, since their final outcome would be virolysis. This is avoided by complement regulatory molecules, which eith
Human chemokines: an update.: Annu Rev Immunol. 1997;15:675-705. Unique Identifier : AIDSLINE MED/97288753; Baggiolini M; Dewald B; Moser B; Theodor Kocher Institute, University of Bern, Switzerland.; baggiolini@tki.unibe.ch; Interleukin 8, the first chemokine to be characterized, was discovered nearly ten years ago. Today, more than 30 human chemokines are known. They are often upregulated in inflammation and act mainly on leukocytes inducing migration and release responses. The present review deals largely with the new developments of th
Computer-assisted, quantitative cytokine enzyme-linked immunospot analysis of human immune effector cell function.: Biotechniques. 1997 Jun;22(6):1146-9. Unique Identifier : AIDSLINE MED/97331434; Cui Y; Chang LJ; University of Alberta, Edmonton, Canada.; Originally developed for detecting antibody production from B lymphocytes, the enzyme-linked immunospot (ELISPOT) assay was later modified to assess cytokine production from various immune effector cells. Although the ELISPOT assay can detect antibody or cytokine production at the single-cell level, the visual countin
Human immunodeficiency virus and the complement system.: Exp Clin Immunogenet. 1997;14(1):11-5. Unique Identifier : AIDSLINE MED/97331585; Gras G; Legendre C; Richard Y; Dormont D; Service de Neurovirologie, CEA et CRSSA, Fontenay-aux-Roses, France.; gras@dsvidf.cea.fr
Reactive oxygen species and nitric oxide in viral diseases.: Biol Trace Elem Res. 1997 Jan;56(1):107-16. Unique Identifier : AIDSLINE MED/97297045; Peterhans E; Institute of Veterinary Virology, University of Berne, Switzerland.; peterhans@ivv.unibe.ch; Metabolites derived from superoxide (O2.-) and nitric oxide (NO.) play an important role in antimicrobial and antitumoral defense, but may also harm the host. Low levels of such metabolites can also facilitate viral replication because of their mitogenic effects on cells. Most viruses grow better in proliferating cell
Possibilities of a viral etiology for human breast cancer. A review.: Biol Trace Elem Res. 1997 Jan;56(1):131-42. Unique Identifier : AIDSLINE MED/97297048; Pogo BG; Holland JF; Department of Medicine, Mount Sinai School of Medicine, CUNY, New; York, NY 10029, USA.; Previous studies related mouse mammary tumor virus (MMTV) to human breast cancer. However, the presence of human endogenous retroviruses (HERs) confounded these results. We selected a 660-bp sequence of the MMTV env gene with low homology to HER (or any other known gene) and searched for a sequence homologous to it, u
Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection.: Biol Trace Elem Res. 1997 Jan;56(1):31-41. Unique Identifier : AIDSLINE MED/97297041; Look MP; Rockstroh JK; Rao GS; Kreuzer KA; Spengler U; Sauerbruch T; Department of General Internal Medicine, University of Bonn, Germany.; Serum selenium levels were determined cross-sectionally in 57 HIV-infected patients who were classified according to the Centers for Disease Control (CDC) 1993 classification system. Mean serum selenium levels were lower in CDC stage II (58.7 +/- 12.2 micrograms/L; p
The distribution of selenium and mortality owing to acquired immune deficiency syndrome in the continental United States.: Biol Trace Elem Res. 1997 Jan;56(1):43-61. Unique Identifier : AIDSLINE MED/97297042; Cowgill UM; University of Colorado at Boulder, Department of EPO Biology,; Carbondale 81623, USA.; A hypothesis has been proposed that Selenium (Se) concentration in the environment as measured by its uptake by alfalfa, which sorbs Se from the soil in proportion to what is present, exerted an apparent effect on incidence of (acquired immune deficiency syndrome) AIDS such that AIDS mortality within the conterminous
Genomic structures of viral agents in relation to the biosynthesis of selenoproteins.: Biol Trace Elem Res. 1997 Jan;56(1):63-91. Unique Identifier : AIDSLINE MED/97297043; Taylor EW; Nadimpalli RG; Ramanathan CS; Computational Center for Molecular Structure and Design, University of; Georgia, Athens 30601-2352, USA. wtaylor@rx.uga.edu; The genomes of both bacteria and eukaryotic organisms are known to encode selenoproteins, using the UGA codon for seleno-cysteine SeC), and a complex cotranslational mechanism for SeC incorporation into polypeptide chains, involving RNA stem-loop structures. These common features and similar codon usage strongly sugge
Academic pediatrics in the Emma Children's Hospital, Academic Medical Center in Amsterdam (The Netherlands).: Pediatr Hematol Oncol. 1997 May-Jun;14(3):199-203. Unique Identifier : AIDSLINE MED/97328689; Stuve W; Weening RS; Emma Children's Hospital, Academic Medical Center, Amsterdam, The; Netherlands.; In 1988 the Emma Children s Hospital and the department of pediatrics of the Academic Medical Center in Amsterdam (The Netherlands ) merged. With the integration of the Emma Children s Hospital and the academic pediatric department, an academic children s hospital (ECH/ AMC) wa
Wells' syndrome: a pathogenic role for circulating CD4+CD7- T cells expressing interleukin-5 mRNA.: Br J Dermatol. 1997 Jun;136(6):918-23. Unique Identifier : AIDSLINE MED/97360863; Yagi H; Tokura Y; Matsushita K; Hanaoka K; Furukawa F; Takigawa M; Department of Dermatology, Hamamatsu University School of Medicine,; Japan.; Wells syndrome, or eosinophilic cellulitis, is a rare dermatosis characterized histologically by a dermal infiltrate of eosinophils, lymphocytes and histiocytes between collagen bundles and amorphous or granular eosinophilic deposits on collagen, constituting flame figures. We report a 54-year-old woman with eosinoph
Active psoriasis and profound CD4+ lymphocytopenia.: Br J Dermatol. 1997 Jun;136(6):930-2. Unique Identifier : AIDSLINE MED/97360865; Hardman CM; Baker BS; Lortan J; Breuer J; Surentheran T; Powles A; Fry L; Department of Dermatology, St Mary's Hospital, London, U.K.; We report the case of a patient with a long-standing history of widespread chronic plaque psoriasis, who was recently found to have a profound CD4+ lymphocytopenia. He is human immunodeficiency virus (HIV) negative. His psoriasis remains active and widespread, and he has had 60 cutaneous malignancies, including many s
Unusual skin ulceration in an HIV-positive patient who had cutaneous syphilis and neurosyphilis.: Br J Dermatol. 1997 Jun;136(6):946-8. Unique Identifier : AIDSLINE MED/97360870; Tucker SC; Yates VM; Thambar IV; Department of Dermatology, Burnley General Hospital, Burnley,; Lancashire, UK.; We present a case of a patient coinfected with syphilis and the human immunodeficiency virus (HIV) who had unusual and severe cutaneous ulceration. The profound immune defects associated with HIV may lead to an altered clinical presentation and a more aggressive course in patients infected with Treponema pallidum. Des
One and a half decades of the Lugano International Conference on Malignant Lymphoma: variations on a theme or true progress?: Ann Oncol. 1997;8 Suppl 1:1-3. Unique Identifier : AIDSLINE MED/97331088; Ultmann JE; Ong ST; Stupp R; Department of Medicine, University of Chicago, IL, USA.
[Compliance, efficacy and tolerability of the therapeutic regimen recommended by National Consensus on Tuberculosis]: Enferm Infecc Microbiol Clin. 1997 Mar;15(3):129-33. Unique Identifier : AIDSLINE MED/97269476; Colmenero JD; Garcia-Ordonez MA; Sebastian MD; Perez-Ruiz E; Sanchez-Lora J; Sanchez-Gonzalez J; Bentabol G; Juarez C; Unidad de Enfermedades Infecciosas, Hospital Regional Carlos Haya de; Malaga.; BACKGROUND: To study the degree of adhesion, efficacy, and tolerance of therapeutic guidelines advocated by the National Consensus on tuberculosis. METHODS: A prospective study of a cohort of 84 patients receiving a diagnosis of tuberculosis in a Basic General Health Area between 1-3-1993 and 28-2-1994 treated with th
[Fever and cavitated pulmonary infiltrates in a patient with AIDS]: Enferm Infecc Microbiol Clin. 1997 Mar;15(3):165-6. Unique Identifier : AIDSLINE MED/97269484; Gainzarain JC; Sanchez MJ; Gijon P; Padilla B; Berenguer J; Servicio de Microbiologia Clinica y Enfermedades Infecciosas, Hospital; General Universitario Gregorio Maranon, Madrid.
[Bacteremia caused by Corynebacterium urealyticum in 2 patients co-infected with HIV and HBV (letter)]: Enferm Infecc Microbiol Clin. 1997 Mar;15(3):172-3. Unique Identifier : AIDSLINE MED/97269491; Aracil B; Perea B; Barros C; Gomez-Garces JL
[Zalcitabine]: Enferm Infecc Microbiol Clin. 1997 Mar;15(3):177-8. Unique Identifier : AIDSLINE MED/97269494
Progressive multifocal leukoencephalopathy in HIV [editorial]: Int J STD AIDS. 1997 Jun;8(6):351-7. Unique Identifier : AIDSLINE MED/97323154; Sadler M; Nelson MR; Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system caused by infection of oligodendrocytes by JC virus. As patients with HIV survive longer with severe immunodeficiency, the incidence of PML is rising. Diagnosis is not always easy and the gold standard remains his
The ocular complications of HIV and AIDS.: Int J STD AIDS. 1997 Jun;8(6):358-65; quiz 365-7. Unique Identifier : AIDSLINE MED/97323155; Greenwood J; Graham EM; Harrison Wing and Medical Eye Unit, St Thomas' Hospital, London, UK.
Comparison of patients refusing with patients accepting unlinked anonymous HIV testing in an outpatient STD department in The Netherlands.: Int J STD AIDS. 1997 Jun;8(6):368-72. Unique Identifier : AIDSLINE MED/97323156; Postema EJ; Willems PW; de Ridder MA; van der Meijden WI; Department of Dermato-Venereology, University Hospital Rotterdam, The; Netherlands.; From 1 February 1993 to 1 February 1994 all new patients, known patients with new problems, and prostitutes attending the Outpatient Department of Sexually Transmitted Diseases (STD) of the University Hospital Rotterdam were asked to participate in unlinked anonymous human immunodeficiency virus (HIV) testing and to a
STD/AIDS knowledge and risk behaviour among masseuses and bar hostesses in Singapore.: Int J STD AIDS. 1997 Jun;8(6):373-7. Unique Identifier : AIDSLINE MED/97323157; Chan R; Goh CL; National Skin Centre Singapore, Singapore.; Sex workers are not confined to brothels, they also include a variety of individuals who practise part-time in establishments conductive to sexual liaisons. We undertook to study the extent of sex work among masseuses and nightclub hostesses and the level of AIDS and STD knowledge in these 2 groups. The studies were c
Difference of virus populations in HIV carriers in relation to AZT treatment.: Int J STD AIDS. 1997 Jun;8(6):378-81. Unique Identifier : AIDSLINE MED/97323158; Sakamoto T; Wakamiya N; Tochikura A; Tsuchie H; Kurimura T; Department of Viral Infections, Osaka University, Japan.; To analyse the appearance of AZT-resistant HIV in HIV carriers after AZT treatment and compare the mutations responsible for resistance employing cloned HIV DNA derived from provirus and free virions in plasma, serial blood specimens were taken before and after AZT treatment. RNA in virions in plasma, proviral DNA and
The epidemiology of notified genital Chlamydia trachomatis infection in Victoria, Australia: a survey of diagnosing providers.: Int J STD AIDS. 1997 Jun;8(6):382-7. Unique Identifier : AIDSLINE MED/97323159; Thompson SC; McEachern KA; Stevenson EM; Forsyth JR; Epidemiology and Social Research Unit, Macfarlane Burnet Centre for; Medical Research, Fairfield, Victoria, Australia.; Data on 259 notified cases of genital chlamydia infection diagnosed in Victoria Australia in January and February 1995 were augmented by call-back. Risk factor data was available for 221. Patients were primarily adolescents or young adults (median age 23 years); 66% were women.
Lack of behavioural risk factors for squamous intraepithelial lesions (SIL) in HIV-infected women.: Int J STD AIDS. 1997 Jun;8(6):388-92. Unique Identifier : AIDSLINE MED/97323160; Heard I; Jeannel D; Bergeron C; Saada M; Henrion R; Kazatchkine MD; Service d'Immunologie, INSERM U 430, Hopital Broussais, Paris, France.; HIV-infected women have a high prevalence of abnormal Papanicolaou smears and cervical intraepithelial neoplasia. A multiparametric analysis of epidemiological and behavioural risk factors has been performed in a cohort of 204 HIV-infected women in an outpatient clinic with the aim to investigate risk factors associat
Severe primary HIV-1 infection among black persons in Barbados.: Int J STD AIDS. 1997 Jun;8(6):393-7. Unique Identifier : AIDSLINE MED/97323161; Hudson CP; Levett PN; Edwards CN; Moosai R; Roach TC; Department of Medicine, University of the West Indies, Queen Elizabeth; Hospital, Barbados.; Descriptions of primary HIV-1 infection have so far been based on Caucasians living in industrialized nations. Due to studies of leptospirosis in the predominantly black population of Barbados , serum was available for patients admitted with acute febrile illnesses to the Queen El
Rise in sexually transmitted diseases during democratization and economic crisis in Mongolia.: Int J STD AIDS. 1997 Jun;8(6):398-401. Unique Identifier : AIDSLINE MED/97323162; Purevdawa E; Moon TD; Baigalmaa C; Davaajav K; Smith ML; Vermund SH; National Center for Hygiene, Epidemiology and Microbiology, Ministry; of Health, Ulaanbaatar, Mongolia.; In 1990, democratic changes and loss of Soviet economic subsidies led to enormous social upheaval in Mongolia . The objective of this study is to map sexually transmitted disease (STD) trends in Mongolia from 1983-1995 and review human immunodeficiency virus HIV) surveillance data
Hypercalcaemia in a patient with AIDS and Mycobacterium avium intracellulare infection.: Int J STD AIDS. 1997 Jun;8(6):405. Unique Identifier : AIDSLINE MED/97323164; Newell A; Nelson MR; Kobler Clinic, St Stephens' Centre, Chelsea and Westminster Hospital,; London.
Liposomal amphotericin B and recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) in the treatment of paediatric AIDS-related cryptococcosis.: Int J STD AIDS. 1997 Jun;8(6):406-8. Unique Identifier : AIDSLINE MED/97323165; Manfredi R; Coronado OV; Mastroianni A; Chiodo F; Dipartimento di Medicina Clinica Specialistica e Sperimentale,; Universita di Bologna, Italy.
An audit of the management of pelvic inflammatory disease.: Int J STD AIDS. 1997 Jun;8(6):409-11. Unique Identifier : AIDSLINE MED/97323166; Wales NM; Barton SE; Boag FC; Booth SJ; Smith JR; Department of Genitourinary Medicine, Chelsea and Westminster; Hospital, London, UK.
Genital warts, trichomoniasis and other concurrent STIs in Scotland [letter]: Int J STD AIDS. 1997 Jun;8(6):412. Unique Identifier : AIDSLINE MED/97323167; Thompson C
Impact of tuberculosis control measures and crowding on the incidence of tuberculous infection in Maryland prisons.: Clin Infect Dis. 1997 Jun;24(6):1060-7. Unique Identifier : AIDSLINE MED/97338498; MacIntyre CR; Kendig N; Kummer L; Birago S; Graham NM; National Centre for Epidemiology and Population Health, Australian; National University, Canberra, Australia.; Our aim was to determine the incidence of tuberculin skin test TST) conversion in the Maryland state correctional system. We conducted a historical longitudinal cohort study. A sample of 1,289 inmates, incarcerated in 16 of 23 prisons, who had a negative TST and a second test within 24 months was selected. The inciden
Photo quiz. Choroidal lesions of disseminated cryptococcosis.: Clin Infect Dis. 1997 Jun;24(6):1079, 1239. Unique Identifier : AIDSLINE MED/97338500; Rajagopalan S; Fong DS; Boyapalli R; Department of Internal Medicine, King/Drew Medical Center, Charles R.; Drew University of Medicine and Science, Los Angeles, California, USA.
Case-control study of risk factors for Penicillium marneffei infection in human immunodeficiency virus-infected patients in northern Thailand.: Clin Infect Dis. 1997 Jun;24(6):1080-6. Unique Identifier : AIDSLINE MED/97338501; Chariyalertsak S; Sirisanthana T; Supparatpinyo K; Praparattanapan J; Nelson KE; Department of Community Medicine, Faculty of Medicine, Chiang Mai; University, Thailand.; A case-control study was done in Chiang Mai, Thailand , comparing risk-related behavior and exposures in 80 incident cases of disseminated Penicillium marneffei infection in patients with AIDS and 160 control patients with AIDS who did not have P. marneffei infection. All subjects
Use of polymerase chain reaction assays of aqueous humor in the differential diagnosis of retinitis in patients infected with human immunodeficiency virus.: Clin Infect Dis. 1997 Jun;24(6):1100-6. Unique Identifier : AIDSLINE MED/97338504; Danise A; Cinque P; Vergani S; Candino M; Racca S; De Bona A; Novati R; Castagna A; Lazzarin A; Department of Infectious Diseases, San Raffaele Scientific Institute,; Milan, Italy.; We performed polymerase chain reaction (PCR) for detection of cytomegalovirus ( CMV ), varicella-zoster virus (VZV), herpes simplex virus (HSV), and Toxoplasma gondii DNA in aqueous humor from 15 patients who were infected with
Prevalence of Campylobacter-associated diarrhea among patients infected with human immunodeficiency virus [see comments]: Clin Infect Dis. 1997 Jun;24(6):1107-13. Unique Identifier : AIDSLINE MED/97338505; Snijders F; Kuijper EJ; de Wever B; van der Hoek L; Danner SA; Dankert J; Department of Medical Microbiology, University of Amsterdam, The; Netherlands.; We performed a cross-sectional study at an outpatient AIDS clinic to assess the prevalence of Campylobacter species in stool specimens from 201 consecutive patients infected with human immunodeficiency virus (HIV). We characterized campylobacters phenotypically and genetically by using primers for the group of common
Diversity of Campylobacter species and its impact on patients infected with human immunodeficiency virus [editorial; comment]: Clin Infect Dis. 1997 Jun;24(6):1114-7. Unique Identifier : AIDSLINE MED/97338506; Quinn TC
Disseminated bacille Calmette-Guerin disease after vaccination: case report and review.: Clin Infect Dis. 1997 Jun;24(6):1139-46. Unique Identifier : AIDSLINE MED/97338512; Talbot EA; Perkins MD; Fagundes S; Silva M; Frothingham R; Department of Medicine, Duke University Medical Center, Durham, North; Carolina, USA.; The attenuated bacille Calmette-Guerin (BCG) vaccine is administered to prevent tuberculosis. Complications of vaccination are uncommon. We report a new case of disseminated BCG disease and review 27 additional cases identified from a review of > 5,000 reports published between 1980 and 1996. Twenty-four of the 28 tot
Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology.: Clin Infect Dis. 1997 Jun;24(6):1195-203. Unique Identifier : AIDSLINE MED/97338522; McKinsey DS; Spiegel RA; Hutwagner L; Stanford J; Driks MR; Brewer J; Gupta MR; Smith DL; O'Connor MC; Dall L; Infectious Disease Associates of Kansas City, University of; Missouri-Kansas City School of Medicine, St. Luke's Hospital, USA.; Histoplasmosis is a common opportunistic infection in patients with human immunodeficiency virus (HIV) infection who reside in areas where Histoplasma capsulatum is endemic. We undertook a prospective study of a cohort of 304 HIV-Infected patients in Kansas City from October 1990 through March 1993 to define the incid
Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.: Clin Infect Dis. 1997 Jun;24(6):1204-7. Unique Identifier : AIDSLINE MED/97338523; Pons V; Greenspan D; Lozada-Nur F; McPhail L; Gallant JE; Tunkel A; Johnson CC; McCarty J; Panzer H; Levenstein M; Barranco A; Green S; Division of Infectious Disease, University of California Hospital, San; Francisco 94143, USA.; A total of 167 human immunodeficiency virus (HIV)-infected patients with oropharyngeal candidiasis were randomly assigned to receive 14 days of therapy with liquid suspension fluconazole 100 mg once daily) or liquid nystatin (500,000 U four times daily). At day 14, 87% of the fluconazole-treated patients were clinical
Adverse reactions to thalidomide in patients infected with human immunodeficiency virus.: Clin Infect Dis. 1997 Jun;24(6):1223-7. Unique Identifier : AIDSLINE MED/97338527; Haslett P; Tramontana J; Burroughs M; Hempstead M; Kaplan G; Laboratory of Cellular Physiology and Immunology, Rockefeller; University, New York, New York 10021-6399, USA.; Thalidomide is emerging as a useful agent in the management of several complications of disease due to human immunodeficiency virus (HIV). We conducted three prospective studies of 56 HIV-infected patients who were treated with thalidomide for 14-21 days; 24 (43%) of these patients discontinued therapy owing to advers
Mycobacterium kansasii disease in patients infected with human immunodeficiency virus.: Clin Infect Dis. 1997 Jun;24(6):1233-8. Unique Identifier : AIDSLINE MED/97338529; Campo RE; Campo CE; Adult AIDS Program, University of Miami School of Medicine, Florida; 33101-6960, USA.; We evaluated the presenting characteristics, response to therapy, and outcome for 46 patients infected with Mycobacterium kansasii and human immunodeficiency virus (HIV). M. kansasii infection occurred late in HIV disease (mean CD4 lymphocyte count, 52.4/mm3), when most patients had already developed AIDS; 91.3% of th
Systemic infection with Mycobacterium genavense following immunosuppressive therapy in a patient who was seronegative for human immunodeficiency virus.: Clin Infect Dis. 1997 Jun;24(6):1245-7. Unique Identifier : AIDSLINE MED/97338532; Bogdan C; Kern P; Richter E; Tannapfel A; Rusch-Gerdes S; Kirchner T; Solbach W; Department for Internal Medicine III, University of Erlangen, Germany.; We describe, to our knowledge, the first case of disseminated Mycobacterium genavense infection in a patient who was seronegative for human immunodeficiency virus. The patient, a 47-year-old woman, had been previously treated with immunosuppressive drugs for 9 months to control an unclassified immunologic disorder cha
Clinical significance of splenic tuberculosis in patients infected with human immunodeficiency virus.: Clin Infect Dis. 1997 Jun;24(6):1248-51. Unique Identifier : AIDSLINE MED/97338533; Gonzalez-Lopez A; Dronda F; Alonso-Sanz M; Chaves F; Fernandez-Martin I; Lopez-Cubero L; Unidad de Enfermedades Infecciosas-Microbiologia Clinica, Hospital; General Penitenciario, Madrid, Spain.; To assess the clinical significance of splenic tuberculosis in patients infected with human immunodeficiency virus (HIV) type 1, we compared 20 patients who had splenic tuberculosis with 20 randomly selected, HIV-infected patients with culture-proven tuberculosis for whom splenic involvement had been ruled out by ultr
Clinical profile of herpes zoster ophthalmicus in Ethiopians.: Clin Infect Dis. 1997 Jun;24(6):1256-60. Unique Identifier : AIDSLINE MED/97338535; Bayu S; Alemayehu W; Department of Ophthalmology, Faculty of Medicine, Addis Ababa; University, Ethiopia, East Africa.; We conducted a prospective study of 100 consecutive Ethiopian patients with herpes zoster ophthalmicus (HZO); this study revealed a high incidence of HZO among the young (mean age, 35 years). Eighty-one (95%) of 85 patients who underwent serological testing were seropositive for antibodies to human immunodeficiency vi
Rifampin-resistant Mycobacterium kansasii infection in a patient with AIDS who was receiving rifabutin.: Clin Infect Dis. 1997 Jun;24(6):1262-3. Unique Identifier : AIDSLINE MED/97338537; Meynard JL; Lalande V; Meyohas MC; Petit JC; Frottier J; Service des Maladies Infectieuses et Tropicales, Hopital; Saint-Antoine, Paris, France.
Pneumocystis carinii Pneumonia in Asians and Pacific Islanders.: Clin Infect Dis. 1997 Jun;24(6):1265-7. Unique Identifier : AIDSLINE MED/97338540; Eckholdt H; Chin J; Division of Tuberculosis Elimination, Centers for Disease Control and; Prevention, Atlanta, Georgia, USA.
Cutaneous Mycobacterium avium complex infection at an intramuscular injection site in a patient with AIDS.: Clin Infect Dis. 1997 Jun;24(6):1273-4. Unique Identifier : AIDSLINE MED/97338546; Meadows JR; Carter R; Katner HP; Department of Internal Medicine, Mercer University School of Medicine,; Macon, Georgia 31201, USA.
Severe recalcitrant erythematous desquamating disorder associated with fatal recurrent toxic shock syndrome in a patient without AIDS.: Clin Infect Dis. 1997 Jun;24(6):1274-5. Unique Identifier : AIDSLINE MED/97338547; Verbon A; Fisher CJ Jr; Department of Internal Medicine, Academic Medical Center, Amsterdam,; The Netherlands.
Structure-activity relationships in quinoline Reissert derivatives with HIV-1 reverse transcriptase inhibitory activity.: Drug Des Discov. 1997 Apr;14(4):259-72. Unique Identifier : AIDSLINE MED/97341686; Font M; Monge A; Ruiz I; Heras B; Dpt. of Medicinal Chemistry, Centro de Investigacion en; Farmacobiologia Aplicada, Universidad de Navarra, Pamplona, Espana.; The relationship between the chemical structure and the HIV-1 RT inhibitory activity has been studied for a series of quinoline derivatives. Two methods were used: a standard QSAR analysis, by combining the methods of Hansch and Free-Wilson, and an analysis using quantum chemistry indices as descriptor parameters, by
Synthesis and evaluation of new Reissert analogs as HIV-1 RT inhibitors. 2. Benzo[f]quinoline and pyridine derivatives.: Drug Des Discov. 1997 Apr;14(4):291-303. Unique Identifier : AIDSLINE MED/97341688; Monge A; Alvarez E; San Martin C; Nadal E; Ruiz I; Font M; Martinez-Irujo JJ; Santiago E; Prieto I; Lasarte JJ; Sarobe P; Borras F; Medicinal Chemistry, Universidad de Navarra, Pamplona, Spain.; The synthesis and preliminary evaluation of new benzo[f]quinoline and pyridine derivatives, obtained by application of the Reissert method and its modifications, as HIV-1 RT inhibitors and anti-infectives are presented. The most active products against HIV-1 RT wild type are the ethyl 2-cyano-1,2-dihydrobenzo[f]quinol
Synthesis and evaluation of new Reissert analogs as HIV-1 reverse transcriptase inhibitors. 1. Quinoline and quinoxaline derivatives.: Drug Des Discov. 1997 Apr;14(4):305-32. Unique Identifier : AIDSLINE MED/97341689; Font M; Monge A; Alvarez E; Cuartero A; Losa MJ; Fidalgo MJ; SanMartin C; Nadal E; Ruiz I; Merino I; Martinez-Irujo JJ; Alberdi E; Santiago E; Prieto I; Lasarte JJ; Sarobe P; Borras F; Medicinal Chemistry, Universidad de Navarra, Pamplona, Spain.; The synthesis and preliminary evaluation of new quinoline and quinoxaline derivatives (obtained by applying the original Reissert method, conveniently modified) as HIV-1 Reverse Transcriptase (RT) inhibitors are presented in this paper; likewise, the first structure-activity relationships are also proposed. Propyl 2-c
Review article: the therapy of gastrointestinal infections associated with the acquired immunodeficiency syndrome.: Aliment Pharmacol Ther. 1997 Jun;11(3):425-43. Unique Identifier : AIDSLINE MED/97361172; Wilcox CM; Monkemuller KE; Department of Medicine, University of Alabama of Birmingham; 35294-0007.; Although there have been dramatic strides in the therapy of human immunodeficiency virus infection over the last few years, the number of infected people world-wide is tremendous and, at least in developing countries, continues to expand. Complications which involve the gastrointestinal tract are common in these patie
[Radiographic findings in Pneumocystis carinii pneumonia and its complications in HIV patients]: An Med Interna. 1997 Mar;14(3):114-8. Unique Identifier : AIDSLINE MED/97275479; Marin Rodriguez C; Gallego Herrero C; Sanchez-Nistal MA; Rasero Ponferrada M; Servicio de Radiodiagnostico, Hospital Universitario 12 de Octubre,; Madrid.; We have performed a retrospective study of 61 cases of Pneumocystis carinii pneumonia (PCP) among the Human Immunodeficiency Virus (HIV) seropositive population at the 11th Health Area of the Comunidad de Madrid with microbiological diagnosis until January 1994. We made an Epidemiologic analysis of this PCP group and
[Association of lung adenocarcinoma and human immunodeficiency virus infection]: An Med Interna. 1997 May;14(5):250-2. Unique Identifier : AIDSLINE MED/97347552; De Miguel Diez J; Gaspar Alonso-Vega G; Pontes Valero J; Mateo Rodriguez O; Gomez Santos D; Serrano Iglesias JA; Servicio de Neumologia, Hospital Universitario de Getafe, Madrid.; In the past decade, few studies have reported the occurrence of lung cancer in HIV-infected patients. The true frequency of this association is known. The major features of these patients include: male gender, young age, a history of intravenous drug abuse, preponderance of adenocarcinoma cell type and advanced clinic
[Tuberculosis and HIV infection: epidemiology (the first of three parts)]: An Med Interna. 1997 May;14(5):253-6. Unique Identifier : AIDSLINE MED/97347553; Martinez Vazquez JM; Cabarcos Ortiz de Barron A; Barrio Gomez E; Servicio de Medicina Interna, Complejo Hospitalario Universitario de; Santiago, Santiago de Compostela, La Coruna.
[Cryptococcal meningitis in an intravenous drug abuse HIV negative person (letter)]: An Med Interna. 1997 May;14(5):264-5. Unique Identifier : AIDSLINE MED/97347557; Nerin Sanchez C; Hermida Lazcano I; Martinez Alvarez R; Arazo Garces P; Figueras Villalba P; Aguirre Errasti JM
A stochastic model for the analysis of bivariate longitudinal AIDS data.: Biometrics. 1997 Jun;53(2):542-55. Unique Identifier : AIDSLINE MED/97335784; Sy JP; Taylor JM; Cumberland WG; Department of Biostatistics, University of California, Los Angeles; 90095, USA.; We present a model for multivariate repeated measures that incorporates random effects, correlated stochastic processes, and measurement errors. The model is a multivariate generalization of the model for univariate longitudinal data given by Taylor, Cumberland, and Sy (1994, Journal of the American Statistical Associ
Assessing interrater agreement from dependent data.: Biometrics. 1997 Jun;53(2):707-14. Unique Identifier : AIDSLINE MED/97335793; Williamson JM; Manatunga AK; Division of HIV/AIDS (E-48), Centers for Disease Control and; Prevention, Atlanta, Georgia 30333, USA.; Estimation of interrater agreement for ordered categorical data is examined when the same sample is being assessed by various raters with different methods. We investigate the use of a latent model proposed by Qu, Piedmonte, and Medendorp (1995, Biomerics 51, 268-275) to estimate the correlation between raters for eac
Weighted logrank tests to detect a transient improvement in survivorship.: Biometrics. 1997 Jun;53(2):736-44. Unique Identifier : AIDSLINE MED/97335795; Wallenstein S; Berger A; Department of Biomathematical Sciences, Mount Sinai School of; Medicine, New York, New York 10029, USA.; In investigating whether an intervention has an effect on survival, we exploit the flexibility of weighted logrank tests for constructing optimal tests sensitive to specified patterns of changes in the ratios or differences of the hazards as a function of time. The tests presented seem appropriate if either the interv
Regional decreases [corrected] in AMPA receptor density in mice infected with the LP-BM5 murine leukemia virus [published erratum appears in Neuroreport 1997 Jul 5;8(9-10):2410]: Neuroreport. 1997 Mar 24;8(5):1243-7. Unique Identifier : AIDSLINE MED/97318139; Kustova Y; Espey MG; Sei Y; Basile AS; Laboratory of Neuroscience, National Institute of Diabetes and; Digestive and Kidney Diseases, National Institutes of Health,; Bethesda, MD 20892-0008, USA.; The status of alpha-amino-3-hydroxy-5-methyl-4-isoxizole (AMPA) receptors in several brain regions was investigated in a murine model of retrovirus-associated cognitive impairment, the LP-BM5 infected mouse. The Bmax of [3H]AMPA receptors in the cortex, striatum, hippocampus and cerebellum declined by 29-50% as early
Activation of cytotoxic and natural killer T-cell system in patients with hepatocellular carcinoma and cirrhosis.: Ital J Gastroenterol. 1996 Dec;28(9):493-8. Unique Identifier : AIDSLINE MED/97278059; Marafin C; Rinaldi M; Angonese C; De Franchis G; Plebani M; Naccarato R; Farinati F; Cattedra Malattie Apparato Digerente, Universita di Padova, Italy.; The immune response in liver cirrhosis and hepatocellular carcinoma is receiving renewed attention in consideration of the possible treatment with biological response modifiers. The aim of this study was to evaluate whether cirrhosis and hepatocellular carcinoma induce any modification in peripheral lymphocyte subsets
Intraepidermal IgA pustulosis associated with monoclonal IgA gammopathy in an HIV-infected patient [letter]: Dermatology. 1997;194(3):308-9. Unique Identifier : AIDSLINE MED/97331528; Barnadas MA; Nadal C; Verger G; Gelpi C; Rodriguez JL; de Moragas JM
Modeling the impact of HIV on the spread of tuberculosis in the United States.: Math Biosci. 1997 Jul 1;143(1):35-60. Unique Identifier : AIDSLINE MED/97342242; West RW; Thompson JR; Department of Statistics, University of South Carolina, Columbia; 29208, USA.; Tuberculosis (TB) was thought to be safely in decline in the United States in the mid-1980s because the number of cases had dropped by 74% between 1953 and 1985. An increase in TB cases was reported, however, in 1986, and an upward trend in TB incidence has continued. The turnaround in
[The antibiotic resistance of Staphylococcus aureus strains isolated in units with an elevated nosocomial risk and in outpatient facilities in 1995]: Bacteriol Virusol Parazitol Epidemiol. 1997 Jan-Jun;42(1-2):51-4. Unique Identifier : AIDSLINE MED/97344442; Grigore L; Dumitrescu V; Sfartz S; Codita I; Institutul Cantacuzino, Bucuresti.; Antibiotic susceptibility testing in 231 strains of S. aureus isolated from patients highly exposed to the nosocomial risk and from patients treated in ambulatories for staphylococcal infections revealed significant discrepancies in respect to the incidence of multiple resistant strains and dispersion of resistance ph
[The specific serological profile in hepatitis B virus infection in children]: Bacteriol Virusol Parazitol Epidemiol. 1997 Jan-Jun;42(1-2):55-7. Unique Identifier : AIDSLINE MED/97344443; Iancu LS; Moraru E; Gotia S; Apetrei C; Azoicai D; Ivan A; Duca M; U.M.F. Gr. T. Popa, Iasi, Disciplina de Microbiologie.; Hepatitis B virus infection (HBV) has a very well known specific serologic profile. In the last years the molecular biology methods reveal some particular serological profiles by genomic mutation. One particular profile consists in the absence of anti-HBc total antibodies simultaneously with the presence of HBsAg. O
[Hepatitis B virus reactivation in patients infected with HIV]: Bacteriol Virusol Parazitol Epidemiol. 1997 Jan-Jun;42(1-2):59-63. Unique Identifier : AIDSLINE MED/97344444; Ciutica I; Bastides F; Besnier M; Barin F; Choutet P; Clinica de Boli Infectioase, UMF Cluj Napoca, Romania.; The authors study the reactivation of B hepatitis virus in three HIV infected patients, correlating the moment of reactivation of and the CD4 and CD8 lymphocytes. Prior to the B viral reactivation, the three patients were with Ac HBc IgG (+) in serum, assessing that the presence of AC HBc IgG is insufficient to preven
[The epidemiological considerations of the evolution of HIV/AIDS in Iasi County in 1990-1995]: Bacteriol Virusol Parazitol Epidemiol. 1997 Jan-Jun;42(1-2):77-80. Unique Identifier : AIDSLINE MED/97344447; Ivan A; Mitroi I; Azoicai D; Grigorescu R; Dragomir C; Duceag L; U.M.F. Gr. T. Popa, Iasi.
[The impact of an AIDS hotline service on pupils and students]: Bacteriol Virusol Parazitol Epidemiol. 1997 Jan-Jun;42(1-2):81-3. Unique Identifier : AIDSLINE MED/97344448; Duma OO; Universitatea de Medicina si Farmacie Iasi.
[Opinions on the rights of seropositive persons or AIDS patients and the conduct adopted towards them]: Bacteriol Virusol Parazitol Epidemiol. 1997 Jan-Jun;42(1-2):85-6. Unique Identifier : AIDSLINE MED/97344449; Tuchendria E; Duma O; C.M.S.S.C. Iasi.
Russia fears rapid increase in HIV infection [news]: BMJ. 1997 Jun 21;314(7097):1783. Unique Identifier : AIDSLINE MED/97367371; Ingram M
HIV associated tuberculosis [editorial]: BMJ. 1997 Jun 28;314(7098):1847. Unique Identifier : AIDSLINE MED/97367412; Coker R; Miller R
AIDS turnaround: first remedy the adverse effects of the condom policy [letter]: Eur J Cancer Prev. 1997 Feb;6(1):96-9. Unique Identifier : AIDSLINE MED/97305561; Gjorgov AN
Trace elements and vitamins in immunomodulation in infancy and childhood.: Eur J Cancer Prev. 1997 Mar;6 Suppl 1:S69-77. Unique Identifier : AIDSLINE MED/97309726; Zuin G; Principi N; Clinica Pediatrica IV, Universita di Milano, Italy.; It has been established that there is a strict and cyclical relationship between infection, immune function and nutritional status with changes in one influencing the other two. Impairment of immune function can occur even in healthy subjects in apparently good nutritional status as a consequence of some nutrient defi
Antiviral substance from silkworm faeces: purification and its chemical characterization.: Biol Pharm Bull. 1997 May;20(5):547-55. Unique Identifier : AIDSLINE MED/97322283; Hiraki A; Yukawa M; Kim J; Ueda S; Institute of Molecular and Cellular Biology for Pharmaceutical; Sciences, Kyoto Pharmaceutical University, Yamashina-ku, Japan.; In a previous paper, we reported that an extract of silkworm faeces has a marked antiviral activity on enveloped viruses, but not on a non-enveloped virus, and we showed that it inhibits the synthesis of a viral specific gene of HVJ (Sendai virus) without affecting the viral adsorption and entry into the host cell. In
Protein delivery from biodegradable microspheres.: Pharm Biotechnol. 1997;10:1-43. Unique Identifier : AIDSLINE MED/97304082; Cleland JL; Genentech, Inc., South San Francisco, California 94080, USA.; The key components to the successful development of a biodegradable microsphere formulation for the delivery of proteins are polymer chemistry, engineering, and protein stability. These areas are intricately related and require a thorough investigation prior to embarking on the encapsulation of proteins. While each of
A case of central cord syndrome caused by intubation: a case report.: J Spinal Cord Med. 1997 Apr;20(2):230-2. Unique Identifier : AIDSLINE MED/97289829; Yan K; Diggan MF; Department of Rehabilitation Medicine and Restorative Sciences,; University of Illinois at Chicago 60612, USA.; Following intubation for respiratory distress, a 42 year-old female patient sustained a hyperextension injury which produced a central cord syndrome. This paper illustrates an unusual mechanism whereby a central cord syndrome was caused by pure hyperextension without high velocity force.
[Consequences of carriage for caregivers and for the patient of a possible presumption of viral (HIV) contamination of a patient by a caregiver]: Bull Acad Natl Med. 1997 Feb;181(2):361-7. Unique Identifier : AIDSLINE MED/97342134; Henrion R
Multistage regulation of Th1-type immune responses by the transcription factor IRF-1.: Immunity. 1997 Jun;6(6):673-9. Unique Identifier : AIDSLINE MED/97352445; Taki S; Sato T; Ogasawara K; Fukuda T; Sato M; Hida S; Suzuki G; Mitsuyama M; Shin EH; Kojima S; Taniguchi T; Asano Y; Department of Immunology, Faculty of Medicine, University of Tokyo,; Japan.; Eradication of a given pathogen is dependent on the selective differentiation of T helper (Th) cells into Th1 or Th2 types. We show here that T cells from mice lacking the transcription factor IRF-1 fail to mount Th1 responses and instead exclusively undergo Th2 differentiation in vitro. Compromised Th1 differentiatio
Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo.: Immunity. 1997 Jun;6(6):681-9. Unique Identifier : AIDSLINE MED/97352446; Lohoff M; Ferrick D; Mittrucker HW; Duncan GS; Bischof S; Rollinghoff M; Mak TW; Ontario Cancer Institute, and the Department of Immunology, University; of Toronto, Canada.; The transcription factor interferon regulatory factor-1 (IRF-1) mediates the effects of IFN. No information exists on its role in lymphokine production. Protection against the intracellular pathogen Leishmania major depends on a Th1 response. Here, we show that CD4+ T cells from Leishmania-infected mice lacking one or
[An experimental study on injury of intestinal immuno-barrier in rat after scald]: Chung Hua Cheng Hsing Shao Shang Wai Ko Tsa Chih. 1996 Mar;12(2):86-9. Unique Identifier : AIDSLINE MED/97350376; Yu Y; Sheng ZY; Tian H; Trauma Center, 304th Hospital of People's Liberation Army, Beijing.; A dynamic observation on injury of intestinal immuno-barrier in scalded rat was performed to investigate the relationship between the injury of intestinal immuno-barrier and bacterial translocation. After 40% TBSA third degree scald, a decrease of IgA in intestinal content and the number of CD3+ and CD4+ T lymphocyte,
Indinavir-induced nephropathy.: Tenn Med. 1997 Jul;90(7):286-8. Unique Identifier : AIDSLINE MED/97359311; Weber L; Campbell H; Gritter NJ; Vanderbilt University Medical Center, Nashville, USA.
Genetic alterations of p53 and ras genes in 1,3-butadiene- and 2',3'-dideoxycytidine-induced lymphomas.: Cancer Res. 1997 Jul 1;57(13):2710-4. Unique Identifier : AIDSLINE MED/97349077; Zhuang SM; Cochran C; Goodrow T; Wiseman RW; Soderkvist P; Department of Cell Biology, Faculty of Health Sciences, University; Hospital, Linkoping University, Sweden.; Mutations of p53 and ras genes were analyzed in 40 and 31 1,3-butadiene (BD)-induced lymphomas of B6C3F1 mice (BLFs), respectively, and in 63 2 ,3 -dideoxycytidine-induced lymphomas, which were collected from B6C3F1 (n = 16) or NIH Swiss mice DLSs; n = 47). The frequencies of K- and N-ras mutations in BLFs 32 and 13%,
Respiratory illness in HIV-negative immunocompromised patients.: Curr Opin Pulm Med. 1997 Mar;3(2):125-30. Unique Identifier : AIDSLINE MED/97337116; Tietjen PA; White DA; Saint Vincent's Hospital and Medical Center, New York, NY 10011, USA.; Pulmonary complications in immunosuppressed patients continue to be a source of morbidity and mortality. Prophylaxis, early recognition, and aggressive treatment remain the keys to management.
Nontuberculous mycobacteria.: Curr Opin Pulm Med. 1997 Mar;3(2):139-45. Unique Identifier : AIDSLINE MED/97337118; Griffith DE; University of Texas Health Center, Tyler, Center for Pulmonary; Infectious Disease Control 75710, USA.; The nontuberculous mycobacteria (NTM), especially Mycobacterium avium complex, are being recognized with increasing frequency as clinical pathogens, not only as a cause of disseminated disease in patients with AIDS but also as a cause of chronic lung disease in patients without AIDS. These infections have traditionall
Pulmonary complications of HIV infection.: Curr Opin Pulm Med. 1997 Mar;3(2):151-8. Unique Identifier : AIDSLINE MED/97337120; Schneider RF; Rosen MJ; Beth Israel Medical Center, Division of Pulmonary and Critical Care; Medicine, New York, NY 10003, USA.; With changes in epidemiology and the application of newer treatment and prophylactic regimens, the types of pulmonary diseases that occur in HIV-infected persons are changing. New ways to assess the progression of HIV disease and new antiretroviral treatments are available. Increased survival is often coupled with wor
Incidence, etiologic pathogens, and diagnostic testing of community-acquired pneumonia.: Curr Opin Pulm Med. 1997 Mar;3(2):89-97. Unique Identifier : AIDSLINE MED/97337110; File TM Jr; Tan JS; Department of Medicine, Northeastern Ohio Universities College of; Medicine, Akron 44304, USA.; Determination of the etiologic pathogens of community-acquired pneumonia has been problematic because of the lack of reliable rapid laboratory diagnostic tools as well as the controversy concerning diagnostic criteria. In the studies reviewed here, a specific pathogen was identified in 39% to 88% of patients. Streptoc
Neuropathogenesis of HIV-1 infection: interactions between interleukin-1 and transforming growth factor-beta 1.: Mol Psychiatry. 1997 Mar;2(2):111-2. Unique Identifier : AIDSLINE MED/97260134; Vitkovic L; Division of Neuroscience and Behavioral Science, National Institute of; Mental Health, National Institutes of Health, Rockville, MD 20857,; USA. vitkovic@helix.nih.gov; Cytokines are widely considered to function as major mediators of neuropathogenesis of HIV-1 infection. This view is based on a large amount of data obtained in vitro, in animal models and in human brain tissue obtained postmortem. Evidence for the involvement of interleukin-1 and transforming growth factor-beta 1, su
Use of Norplant implants in asymptomatic HIV-1 infected women.: Contraception. 1997 Apr;55(4):205-7. Unique Identifier : AIDSLINE MED/97322961; Taneepanichskul S; Intaraprasert S; Phuapradit W; Chaturachinda K; Department of Obstetrics and Gynaecology, Faculty of Medicine,; Ramathibodi Hospital, Manidol University, Bangkok, Thailand.; The study of Norplant implants use in HIV-1 infected women was conducted at the Family Planning Clinic, Department of Obstetrics and Gynaecology. Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand , from January 1993 to June 1996. The purpose of the st
Zalcitabine. An update of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of HIV infection.: Drugs. 1997 Jun;53(6):1054-80. Unique Identifier : AIDSLINE MED/97323041; Adkins JC; Peters DH; Faulds D; Adis International Limited, Auckland, New Zealand. demail@adis.co.nz; Zalcitabine is a dideoxynucleoside antiretroviral agent that is phosphorylated to the active metabolite 2 ,3 -dideoxycytidine 5 -triphosphate (ddCTP) within both uninfected and HIV-infected cells. At therapeutic concentrations, ddCTP inhibits HIV replication by inhibiting the enzyme reverse transcriptase and terminati
Mouse lymphoma workshop: Victoria, British Columbia, Canada, March 27, 1996 protocol issues regarding the use of the Microwell Method of the Mouse Lymphoma Assay.: Environ Mol Mutagen. 1997;29(4):434-8. Unique Identifier : AIDSLINE MED/97356360; Sofuni T; Wilcox P; Shimada H; Clements J; Honma M; Clive D; Green M; Thybaud V; San RH; Elliott BM; Muller L; National Institute of Health Sciences, Setagaya-ku, Tokyo, Japan.; sofuni@nihs.go.jp
Long-term transgene expression in fetal rat suprachiasmatic nucleus neurografts following ex vivo adenoviral vector-mediated gene transfer.: Exp Neurol. 1997 Jun;145(2 Pt 1):536-45. Unique Identifier : AIDSLINE MED/97360061; Boer GJ; van Esseveldt KE; Hermens WT; Liu R; Verhaagen J; Graduate School Neurosciences Amsterdam, Netherlands Institute for; Brain Research, Amsterdam.; Ex vivo gene transfer to fetal suprachiasmatic nucleus SCN)-containing solid piece neurografts was explored using a first-generation prototype adenoviral vector containing the reporter gene LacZ (Ad-LacZ). Transgene expression was examined at different intervals following grafting in the IIIrd ventricle of rat brain a
Lung and blood T-cell receptor repertoire in extrinsic allergic alveolitis [see comments]: Eur Respir J. 1997 Apr;10(4):772-9. Unique Identifier : AIDSLINE MED/97294556; Wahlstrom J; Berlin M; Lundgren R; Olerup O; Wigzell H; Eklund A; Grunewald J; Microbiology and Tumor Biology Center, Karolinska Institute,; Stockholm, Sweden.; Patients with extrinsic allergic alveolitis (EAA) have accumulations of T-lymphocytes in their lungs. CD8+ lung T-cells, in particular, have been implicated in the pathogenesis of EAA. The objective of the present study was to analyse the T-cell receptor (TCR) V alpha and V beta gene usage of CD4+ and CD8+ lung and pe
Pleural tuberculosis.: Eur Respir J. 1997 Apr;10(4):942-7. Unique Identifier : AIDSLINE MED/97294582; Ferrer J; Servei de Pneumologia, Hospital General Universitari Vall d'Hebron,; Barcelona, Spain.; Tuberculous pleural effusions occur in up to 30% of patients with tuberculosis. It appears that the percentage of patients with pleural effusion is comparable in human immunodeficiency virus HIV)-positive and HIV-negative individuals, although there is some evidence that HIV-positive patients with CD4+ counts
Pneumothorax in HIV-infected patients: role of Pneumocystis carinii pneumonia and pulmonary tuberculosis.: Eur Respir J. 1997 Jun;10(6):1332-5. Unique Identifier : AIDSLINE MED/97336143; Tumbarello M; Tacconelli E; Pirronti T; Cauda R; Ortona L; Dept of Infectious Diseases, Catholic University, Rome, Italy.; Patients with acquired immune deficiency syndrome (AIDS) are at increased risk for pneumothorax, which usually occurs in the setting of Pneumocystis carinii pneumonia. The rationale of the present study was based on the hypothesis that the increased incidence of pulmonary tuberculosis in human immunodeficiency virus (
ACOG educational bulletin. Human immunodeficiency virus infections in pregnancy. American College of Obstetricians and Gynecologists.: Int J Gynaecol Obstet. 1997 Apr;57(1):73-80. Unique Identifier : AIDSLINE MED/97318738
Report of the FIGO Committee for the Study of Ethical Aspects of Human Reproduction. International Federation of Gynecology and Obstetrics.: Int J Gynaecol Obstet. 1997 Apr;57(1):95-9. Unique Identifier : AIDSLINE MED/97318743; Schenker JG; Hadassah Hospital, Jerusalem.
A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain of Toxoplasma gondii.: Folia Microbiol (Praha). 1996;41(6):513-6. Unique Identifier : AIDSLINE MED/97278534; de Diego JA; Penin P; Arribas JR; Vazquez E; Vazquez JJ; Department of Preventive Medicine and Public Health, Autonomous; University, School of Medicine, Madrid, Spain.; Toxoplasmic encephalitis in pa